<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis - Jagannath, VA - 2019 | Cochrane Library</title> <meta content="Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis - Jagannath, VA - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009903.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis - Jagannath, VA - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009903.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009903.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis" name="citation_title"/> <meta content="Vanitha A Jagannath" name="citation_author"/> <meta content="American Mission Hospital" name="citation_author_institution"/> <meta content="kidzdoc311@gmail.com" name="citation_author_email"/> <meta content="Eugenio Pucci" name="citation_author"/> <meta content="ASUR Marche ‐ Zona Territoriale 9" name="citation_author_institution"/> <meta content="Govindaraj V Asokan" name="citation_author"/> <meta content="University of Bahrain" name="citation_author_institution"/> <meta content="Edward W Robak" name="citation_author"/> <meta content="MS Consumer" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="5" name="citation_issue"/> <meta content="10.1002/14651858.CD009903.pub3" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/05/31" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009903.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009903.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009903.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Angioplasty [*methods]; Cerebrovascular Circulation [*physiology]; Multiple Sclerosis [*complications]; Randomized Controlled Trials as Topic; Venous Insufficiency [etiology, *surgery]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009903.pub3&amp;doi=10.1002/14651858.CD009903.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="jU9oKp1Y";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009903\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009903\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009903\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009903\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","fr","zh_HANS","fa","ms","ja","de"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009903.pub3",title:"Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis",firstPublishedDate:"May 31, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Multiple Sclerosis and Rare Diseases of the CNS Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jU9oKp1Y&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009903.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009903.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009903.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009903.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009903.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009903.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009903.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009903.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009903.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009903.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2245 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009903.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/full#CD009903-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/full#CD009903-sec-0102"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/full#CD009903-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/full#CD009903-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/full#CD009903-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/full#CD009903-sec-0043"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/full#CD009903-sec-0071"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/full#CD009903-sec-0096"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/appendices#CD009903-sec-0107"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/table_n/CD009903StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/table_n/CD009903StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/information#CD009903-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Vanitha A Jagannath</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/information#CD009903-cr-0003">Eugenio Pucci</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/information#CD009903-cr-0004">Govindaraj V Asokan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009903.pub3/information#CD009903-cr-0005">Edward W Robak</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/information/en#CD009903-sec-0120">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 31 May 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009903.pub3">https://doi.org/10.1002/14651858.CD009903.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009903-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009903-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009903-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009903-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009903-abs-0002">Français</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009903-abs-0008">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009903-abs-0001" lang="en"> <section id="CD009903-sec-0001"> <h3 class="title" id="CD009903-sec-0001">Background</h3> <p>Multiple sclerosis (MS) is a leading cause of neurological disability in young adults. The most widely accepted hypothesis regarding its pathogenesis is that it is an immune‐mediated disease. It has been hypothesised that intraluminal defects, compression, or hypoplasia in the internal jugular or azygos veins may be important factors in the pathogenesis of MS. This condition has been named 'chronic cerebrospinal venous insufficiency' (CCSVI). It has been suggested that these intraluminal defects restrict the normal blood flow from the brain and spinal cord, causing the deposition of iron in the brain and the eventual triggering of an auto‐immune response. The proposed treatment for CCSVI is venous percutaneous transluminal angioplasty (PTA), which is claimed to improve the blood flow in the brain thereby alleviating some of the symptoms of MS. This is an update of a review first published in 2012. </p> </section> <section id="CD009903-sec-0002"> <h3 class="title" id="CD009903-sec-0002">Objectives</h3> <p>To assess the benefit and safety of venous PTA in people with MS and CCSVI.</p> </section> <section id="CD009903-sec-0003"> <h3 class="title" id="CD009903-sec-0003">Search methods</h3> <p>We searched the Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group's Specialised Register up to 30 August 2018, CENTRAL (in the Cochrane Library 2018, issue 8), MEDLINE up to 30 August 2018, Embase up to 30 August 2018, metaRegister of Controlled Trials, ClinicalTrials.gov., the Australian New Zealand Clinical Trials Registry, and the World Health Organization (WHO) International Clinical Trials Registry platform. We examined the bibliographies of the included and excluded studies. </p> </section> <section id="CD009903-sec-0004"> <h3 class="title" id="CD009903-sec-0004">Selection criteria</h3> <p>We included randomised controlled trials (RCTs) in which PTA and sham interventions were compared in adults with MS and CCSVI. </p> </section> <section id="CD009903-sec-0005"> <h3 class="title" id="CD009903-sec-0005">Data collection and analysis</h3> <p>Two authors independently assessed study eligibility and risk of bias, and extracted data. We reported results as risk ratios (RR) with 95% confidence intervals (CI). We performed statistical analyses using the random‐effects model; and we assessed the certainty of the evidence using GRADE. </p> </section> <section id="CD009903-sec-0006"> <h3 class="title" id="CD009903-sec-0006">Main results</h3> <p>We included three RCTs (238 participants) in this update. One hundred and thirty‐four participants were randomised to PTA and 104 to sham treatment. We attributed low risk of bias to two (67%) studies for sequence generation and two (67%) studies for performance bias. All studies were at a low risk of detection bias, attrition bias, reporting bias and other potential sources of bias. </p> <p>There was moderate‐quality evidence to suggest that venous PTA did not increase the proportion of patients who had operative or post‐operative serious adverse events compared with the sham procedure (RR 3.33, 95% CI 0.36 to 30.44; 3 studies, 238 participants); nor did it increase the proportion of patients who improved on a functional composite measure including walking control, balance, manual dexterity, postvoid residual urine volume, and visual acuity over 12‐month follow‐up (RR 0.84, 95% CI 0.55 to 1.30; 1 study, 110 participants); nor did it reduce the proportion of patients who experienced new relapses at six‐ or 12‐month follow‐up (RR 0.87, 95% CI 0.51 to 1.49; 3 studies, 235 participants). There was no effect of venous PTA on disability worsening measured by the Expanded Disability Status Scale, which was reported at follow‐up intervals of six months (one study), 11 months (one study) and 12 months (one study). Quality of life was reported in two studies with no difference between treatment groups. Moderate or severe pain during or post venography was reported in both PTA and sham‐procedure participants in all included studies. Venous PTA was not effective in restoring blood flow assessed at one‐month (one study) or 12‐month follow‐up (one study). </p> </section> <section id="CD009903-sec-0007"> <h3 class="title" id="CD009903-sec-0007">Authors' conclusions</h3> <p>This systematic review identified moderate‐quality evidence that, compared with sham procedure, venous PTA intervention did not provide benefit on patient‐centred outcomes (disability, physical or cognitive functions, relapses, quality of life) in people with MS. Venous PTA has proven to be a safe technique but in view of the available evidence of its ineffectiveness, this intervention cannot be recommended in people with MS. All ongoing trials were withdrawn or terminated and hence this updated review is conclusive. No further randomised clinical studies are needed. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009903-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009903-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009903-abs-0014">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD009903-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009903-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009903-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD009903-abs-0013">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009903-abs-0012">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD009903-abs-0009">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD009903-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009903-abs-0004" lang="en"> <h3>The technique popularly known as 'liberation procedure' for treatment of venous stenoses (CCSVI) in the brain of people with MS </h3> <p><b>What is the issue?</b><br/> Chronic cerebrospinal venous insufficiency (CCSVI) has been described as a vascular condition characterized by restricted venous outflow from the brain and spinal cord, mainly due to narrowing or blockage of the veins in the head and neck. It has been hypothesised that CCSVI may be an important factor in the development of MS and treatment of CCSVI by catheter venography and percutaneous transluminal angioplasty (PTA) to widen the veins might improve symptoms and quality of life in people with MS. There is uncertainty about whether PTA should be used in people with MS. </p> <p><b>What did we do?</b><br/> We reviewed three studies (238 participants) which compared PTA with sham‐PTA in participants with MS and CCSVI. </p> <p><b>What did we find?</b><br/> We found that venous PTA did not provide benefit on disability, physical or cognitive functions, relapses, or quality of life. No serious adverse events attributable to venography or venous PTA occurred. </p> <p><b>Conclusions</b><br/> Venous PTA has proven to be a safe but ineffective intervention and cannot be recommended in patients with MS. All trials that were ongoing were either terminated or withdrawn, so this updated review is conclusive. No further randomised clinical studies are needed. </p> <p><b>Currentness of evidence</b><br/> This review is up to date to August 2018. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009903-sec-0102" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009903-sec-0102"></div> <h3 class="title" id="CD009903-sec-0103">Implications for practice</h3> <section id="CD009903-sec-0103"> <p>This systematic review identified moderate‐quality evidence that, compared with sham procedure, the PTA intervention did not provide benefit on patient‐centred outcomes (disability, physical or cognitive functions, relapse, quality of life) in people with MS. Moreover, the fact that results for restored blood flow were similar for treated and sham groups suggested that PTA was not effective in restoring venous outflow. Venous PTA has proven to be a safe technique but this intervention cannot be recommended in people with MS in view of the available evidence that it is largely ineffective. </p> </section> <h3 class="title" id="CD009903-sec-0104">Implications for research</h3> <section id="CD009903-sec-0104"> <p>No further randomised clinical studies are needed.</p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009903-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009903-sec-0036"></div> <div class="table" id="CD009903-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with multiple sclerosis and chronic cerebrospinal venous insufficiency (CCSVI) </p> <p><b>Settings:</b> MS centres and their associated colour Doppler ultrasonography (ECD) and angiography units </p> <p><b>Intervention:</b> venous percutaneous transluminal angioplasty (PTA) </p> <p><b>Comparison:</b> catheter venography without venous angioplasty (sham) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Reasons for downgrading our confidence in the<br/> evidence</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk with sham procedure</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk with intervention (95%CI)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants who experienced operative or postoperative serious adverse events </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 100</p> <p>(0 to 0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 3.33</p> <p>(0.36 to 30.44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>238</p> <p>(3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 1 level due to <b>imprecision</b>, wide CI </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants who experienced improvement of composite functional endpoint over 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>49 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>41 per 100</p> <p>(27 to 64)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.84,</p> <p>(0.55 to 1.30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> <p>(1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 1 level due to <b>imprecision</b>, wide CI </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants who experienced new relapses over 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>18 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>16 per 100</p> <p>(4 to 27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.87</p> <p>(0.51 to 1.49)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235</p> <p>(3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 1 level due to <b>imprecision</b>, wide CI </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>* The basis for the <b>assumed risk</b> is the sham group risk across studies included in the meta‐analysis. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk with sham procedure and the <b>relative effect</b> of the PTA intervention (and its 95% CI). </p> <p><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009903-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009903-sec-0037"></div> <p>Multiple sclerosis (MS) is an inflammatory disease of the nervous system and the most frequent cause of neurological disability in young adults. Myelin, the material that surrounds and protects the nerves, becomes damaged and this results in the formation of scar‐like plaques. MS is considered to be an immune‐mediated disease in which the person's own immune system attacks the nervous system; and most of the current drug therapies are based on this hypothesis. </p> <p>A theory has been proposed that impaired blood flow in the veins draining the central nervous system, a condition called chronic cerebrospinal venous insufficiency (CCSVI), may play a role in the cause of MS (<a href="./references#CD009903-bbs2-0073" title="ZamboniP . The Big Idea: iron‐dependent inflammation in venous disease and proposed parallels in multiple sclerosis. Journal of the Royal Society of Medicine2006;99(11):589‐93. [PUBMED: PMID: 18045150] ">Zamboni 2006</a>). CCSVI is thought to be congenital and it may result in iron deposits which in turn trigger the immune system to attack the central nervous system, thus damaging the myelin (<a href="./references#CD009903-bbs2-0060" title="SinghAV , ZamboniP . Anomalous venous blood flow and iron deposition in multiple sclerosis. Journal of Cerebral Blood Flow and Metabolism2009;29(12):1867‐78. [PUBMED: PMID: 19724286] ">Singh 2009</a>). The proposed treatment for CCSVI is venous balloon angioplasty, which entails the widening of narrowed (stenosed) veins (<a href="./references#CD009903-bbs2-0074" title="ZamboniP , GaleottiR , MenegattiE , MalagoniAM , GianesiniS , BartolomeiI , et al. A prospective open‐label study of endovascular treatment of chronic cerebrospinal venous insufficiency. Journal of Vascular Surgery2009;50(6):1348‐58. [PUBMED: PMID: 19958985] ">Zamboni 2009a</a>; <a href="./references#CD009903-bbs2-0077" title="ZamboniP , GaleottiR , Weinstock‐GuttmanB , KennedyC , SalviF , ZivadinovR . Venous angioplasty in patients with multiple sclerosis: results of a pilot study. European Journal of Vascular and Endovascular Surgery2012; Vol. 43, issue 1:116‐22. [PUBMED: PMID: 21839654] ">Zamboni 2012</a>). This theory has gained a lot of attention via the Internet, mainly among the participants' community, and increased media interest has further enhanced the expectations of people suffering with MS. This is an update of a review first published in 2012 (<a href="./references#CD009903-bbs2-0081" title="vanZuurenEJ , FedorowiczZ , PucciE , JagannathVA , RobakEW . Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD009903.pub2] ">van Zuuren 2012</a>). </p> <p>Unfamiliar terms are listed in the 'Glossary of terms' in <a href="#CD009903-tbl-0002">Table 1</a>. </p> <div class="table" id="CD009903-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ntigen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Substance or molecule that, when introduced into the body, triggers the production of an antibody by the immune system, which will then kill or neutralise the antigen that is recognised as a foreign and potentially harmful invader </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Autoreactive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immune response acting against own tissue</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ataxia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neurological sign and symptom that consists of gross lack of coordination of muscle movements </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Axon</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Part of the neuron that conducts electrical impulses away from the neuron's cell body</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Central nervous system</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Part of the nervous system that integrates the information that it receives from, and coordinates the activity of, all parts of the body. It comprises the brain and the spinal cord </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cognitive impairment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Condition associated with forgetfulness, difficulty concentrating, or making decisions that affect everyday life. Cognitive impairment ranges from mild to severe. With mild impairment, people may begin to notice changes in cognitive functions, but still be able to do their everyday activities. Severe levels of impairment can lead to losing the ability to understand the meaning or importance of something and the ability to talk or write, resulting in the inability to live independently. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Congestion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Accumulation or overfilling of the blood vessels</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Demyelination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Loss of the myelin sheath insulating the nerves</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dysarthria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Having a problem with articulating</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Erythrocyte extravasation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Leakage of red blood cells into the surrounding tissue</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gliosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proliferation of astrocytes (glial cells) in damaged areas of the central nervous system </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HLA‐DR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Major histocompatability complex (MHC) class II cell surface receptor encoded by the human leukocyte antigen complex on chromosome 6 region 6p21.31. HLA‐DR is also involved in several autoimmune conditions, disease susceptibility and disease resistance. It is also closely linked to HLA‐DQ and this linkage often makes it difficult to resolve the more causative factor in disease </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HLA‐DQ</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A cell surface receptor type protein (MHC class II type) found on antigen presenting cells. The DQ loci are in close genetic linkage to HLA‐DR. When tolerance to self‐proteins is lost, DQ may become involved in autoimmune disease </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immuno‐mediated disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Conditions that result from abnormal activity of the body's immune system</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inflammation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Response of vascular tissues to harmful stimuli and a protective attempt to remove the injurious stimuli and to initiate the healing process. A cascade of biochemical events propagates and matures the inflammatory response, involving the local vascular system, the immune system and various cells within the injured tissue </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Major histocompatability complex (MHC)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A large genomic region or gene family found in most vertebrates that encodes MHC molecules. MHC molecules play an important role in the immune system and autoimmunity </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neuron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An electrically excitable cell that processes and transmits information by electrical and chemical signalling. Chemical signalling occurs via synapses, specialised connections with other cells. Neurons connect to each other to form networks. Neurons are the core components of the nervous system </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Altered or caused by disease</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathogenesis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The mechanism by which the disease is caused</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Phagocytosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mechanism used to remove pathogens and cell debris</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Polygenic disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Disease controlled by several genes at once</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Relapse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An objective new/re‐emerging neurological abnormality present for at least 24 hours in the absence of fever/infection </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reversible</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Capable of returning to an original condition/situation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Stenosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Abnormal narrowing in a blood vessel</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tremor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Involuntary, somewhat rhythmic, muscle contraction and relaxation involving to‐and‐fro movements of 1 or more body parts </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venogram</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An X‐ray test that takes pictures of blood flow through the veins in a certain area of the body </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venotopic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Located in the veins</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venous angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A procedure that can be performed during a venogram to open or bypass veins. It can also be used for placement of a stent, which keeps a vessel or tissue in an open position to allow for improved blood flow </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venous congestion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dilation of veins and capillaries due to impaired venous drainage</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertigo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Type of dizziness, where there is a feeling of motion when one is stationary</p> </td> </tr> </tbody> </table> </div> <section id="CD009903-sec-0038"> <h3 class="title" id="CD009903-sec-0038">Description of the condition</h3> <p>Multiple sclerosis (MS) is a leading cause of neurological disability in young adults. The disease is characterised by focal white matter lesions, characterised by inflammation and demyelination that are associated with axonal damage (<a href="./references#CD009903-bbs2-0038" title="KuhlmannT , LudwinS , PratA , AntelJ , BruckW , LassmannH . An updated histological classification system for multiple sclerosis lesions. Acta Neuropathologica2017;133(1):13‐24. ">Kuhlmann 2017</a>). Four clinical forms of MS can be distinguished: relapsing‐remitting (RRMS); secondary progressive (SPMS); primary progressive (PPMS); and progressive relapsing (PRMS) (<a href="./references#CD009903-bbs2-0041" title="LublinFD , ReingoldSC . Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology1996;46(4):907‐11. [PUBMED: PMID: 8780061] ">Lublin 1996</a>). RRMS and SPMS are the clinical forms of MS that account for approximately 80% to 85% of sufferers, and SPMS evolves from the RRMS form. MS is heterogeneous, both histopathologically and clinically (<a href="./references#CD009903-bbs2-0042" title="LucchinettiC , BrückW , ParisiJ , ScheithauerB , RodriguezM , LassmannH . Heterogeneity of multiple sclerosis lesions:implications for the pathogenesis of demyelination. Annals of Neurology2000;47(6):707‐17. ">Lucchinetti 2000</a>), and the natural history can be difficult to predict. In most cases it begins as RRMS with episodic, largely reversible neurological dysfunction. Natural history studies, which followed cohorts of MS patients not treated with any disease‐modifying drugs, have shown that, after a period of approximately 10 years, almost 50% of people with MS gradually develop permanent disability which may also include acute relapses. After a median of 15 to 28 years from disease onset, a disability milestone equivalent to the use of an assistive walking device is reached (<a href="./references#CD009903-bbs2-0069" title="WeinshenkerBG , BassB , RiceGP , NoseworthyJ , CarriereW , BaskervilleJ , et al. The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain1989;112(Pt 6):1419‐28. [PUBMED: PMID: 2597989] ">Weinshenker 1989</a>). Clinical features include all of the symptoms caused by the impairment of the central nervous system (e.g. loss of vision, double vision, muscle weakness, sensory disturbances, bladder dysfunction, impotence, constipation, ataxia, vertigo, tremor, spasticity, pain, cognitive impairment and dysarthria). Fatigue, anxiety and depression are also frequent occurrences. Magnetic resonance imaging (MRI) can support the clinical diagnosis, and it is integrated with clinical and other para‐clinical diagnostic methods (e.g. examining cerebrospinal fluid and evoked potentials) to facilitate the diagnosis of MS (<a href="./references#CD009903-bbs2-0062" title="ThompsonAJ , BanwellBL , BarkhofF , CarrollWM , CoetzeeT , ComiG , atal . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurology2018;17(2):162‐73. ">Thompson 2018</a>). MRI parameters are also used as surrogate markers of disease activity and progression. The disease has an adverse impact on the health‐related quality of life (HRQoL) of people with MS and their families and may also pose a financial burden, even when the disease is not physically disabling. </p> <p>The age of onset of MS is usually between 20 and 40 years. Incidence is low in childhood and is rarer at the age of 50 years or older. Female‐to‐male ratios vary between 1.5:1 and 2.5:1 in most populations (<a href="./references#CD009903-bbs2-0056" title="SellnerJ , KrausJ , AwadA , MiloR , HemmerB , StüveO . The increasing incidence and prevalence of female multiple sclerosis ‐ a critical analysis of potential environmental factors. Autoimmunity Reviews2011;10(8):495‐502. [PUBMED: PMID: 21354338] ">Sellner 2011</a>). The incidence and prevalence of MS varies geographically (<a href="./references#CD009903-bbs2-0059" title="SimpsonSJr , BlizzardL , OtahalP , Van derMeiI , TaylorB . Latitude is significantly associated with the prevalence of multiple sclerosis: a meta‐analysis. Journal of Neurology, Neurosurgery, and Psychiatry2011;82(10):1132‐41. [PUBMED: PMID: 21478203] ">Simpson 2011</a>): high‐frequency areas (prevalence in excess of 60 per 100,000 people) include all of Europe in addition to southern Canada, northern USA, New Zealand, and south‐east Australia. In many of these areas the prevalence is more than 100 per 100,000 people. This geographic variance may be explained in part by racial differences: white populations, especially those from northern Europe, appear to be most susceptible. </p> <p>The most widely accepted hypothesis on the pathogenesis of MS is that it is an immune‐mediated disease characterised by infiltration of blood‐derived monocytes, microglia, and lymphocytes leading to damage of myelin and axons. Although the aetiology is largely indeterminate, a large proportion of the scientific community considers that MS develops in genetically predisposed subjects and that environmental factors play a central role in its pathogenesis, based on immune‐mediated mechanisms. It is thought that aberrant immune responses to self or foreign antigens cause and perpetuate inflammation (<a href="./references#CD009903-bbs2-0071" title="WuGF , AlvarezE . The immuno‐pathophysiology of multiple sclerosis. Neurologic Clinics2011;29(2):257‐78. [PUBMED: 21439440] ">Wu 2011</a>). The inflammation leads to demyelination and subsequent axonal damage. The role of inflammation is considered to be complex, however, and may include both beneficial and detrimental effects (<a href="./references#CD009903-bbs2-0045" title="MartinoG , AdoriniL , RieckmannP , HillertJ , KallmannB , ComiG , et al. Inflammation in multiple sclerosis: the good, the bad, and the complex. Lancet Neurology2002;1(8):499‐509. [PUBMED: 12849335] ">Martino 2002</a>). </p> <p>The hypothesis suggesting that chronic venous congestion may be a factor in the pathogenesis of MS became a focus in multiple sclerosis research when public participation emphasised interest in the procedure to correct it. (<a href="./references#CD009903-bbs2-0073" title="ZamboniP . The Big Idea: iron‐dependent inflammation in venous disease and proposed parallels in multiple sclerosis. Journal of the Royal Society of Medicine2006;99(11):589‐93. [PUBMED: PMID: 18045150] ">Zamboni 2006;</a><a href="./references#CD009903-bbs2-0076" title="ZamboniP , MenegattiE , Weinstock‐GuttmanB , DwyerMG , SchirdaCV , MalagoniAM , et al. Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross‐sectional preliminary report. BMC Medicine2011;9:22. [PUBMED: PMID: 21385345] ">Zamboni 2011</a>) The predominantly venotopic location of MS lesions in the CNS is postulated to be a consequence of local erythrocyte extravasation owing to elevated transmural venous pressure, followed by erythrocyte degradation and iron‐driven phagocytosis and subsequent lymphocytic infiltration (<a href="./references#CD009903-bbs2-0060" title="SinghAV , ZamboniP . Anomalous venous blood flow and iron deposition in multiple sclerosis. Journal of Cerebral Blood Flow and Metabolism2009;29(12):1867‐78. [PUBMED: PMID: 19724286] ">Singh 2009</a>). This condition has been named 'chronic cerebrospinal venous insufficiency' (CCSVI) and is characterised by stenoses of the internal jugular veins or azygos veins, or both, which restrict the normal blood flow from the brain, along with the appearance of small collateral veins that may have developed to reduce the impact of the stenoses. In his initial study, Zamboni found CCSVI in all subjects in the study group that were diagnosed with MS, and none in the healthy controls (<a href="./references#CD009903-bbs2-0076" title="ZamboniP , MenegattiE , Weinstock‐GuttmanB , DwyerMG , SchirdaCV , MalagoniAM , et al. Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross‐sectional preliminary report. BMC Medicine2011;9:22. [PUBMED: PMID: 21385345] ">Zamboni 2011</a>). CCSVI, as defined by Zamboni and colleagues, is diagnosed with combined extracranial and transcranial echo colour Doppler (ECD) radiography when two or more of five established parameters are present (<a href="./references#CD009903-bbs2-0075" title="ZamboniP , GaleottiR , MenegattiE , MalagoniAM , TacconiG , Dall’AraS , et al. Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry2009;80(4):392–9. ">Zamboni 2009b</a>). </p> <p>There has been some criticism of several of the limitations in the ultrasound‐based investigation used to measure the rather complex and dynamic (i.e. postural dependent) cerebrospinal venous outflow. These include the wide individual variability, operator dependence and intra‐ and inter‐rater bias, the difficulty of standardising values for diagnostic criteria and the necessity of venography as a gold standard (<a href="./references#CD009903-bbs2-0027" title="DoeppF , PaulF , ValduezaJM , SchmiererK , SchreiberSJ . No cerebrocervical venous congestion in patients with multiple sclerosis. Annals of Neurology2010;68(2):173‐83. [PUBMED: PMID: 20695010] ">Doepp 2010</a>; <a href="./references#CD009903-bbs2-0034" title="HojnackiD , ZamboniP , Lopez‐SorianoA , GalleottiR , MenegattiE , Weinstock‐GuttmanB , et al. Use of neck magnetic resonance venography, Doppler sonography and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls. International Angiology2010;29(2):127‐39. [PUBMED: PMID: 20351669] ">Hojnacki 2010</a>; <a href="./references#CD009903-bbs2-0079" title="ZivadinovR , RamanathanM , DolicK , MarrK , KarmonY , SiddiquiAH , et al. Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives. Expert Review of Neurotherapeutics2011;11(9):1277‐94. [PUBMED: 21864074] ">Zivadinov 2011b</a>). A high degree of correlation between CCSVI and MS was found in a number of studies (<a href="./references#CD009903-bbs2-0015" title="Al‐OmariMH , RousanLA . Internal jugular vein morphology and hemodynamics in patients with multiple sclerosis. International Angiology2010;29(2):115‐20. [PUBMED: PMID: 20351667] ">Al‐Omari 2010</a>; <a href="./references#CD009903-bbs2-0019" title="BaveraPM , MendozziL , CavarrettaR , AgusGB . Venous extracranial Duplex ultrasound and possible correlations between multiple sclerosis and CCSVI: an observational study after 560 exams. Acta Phlebologica2011;12(2):109‐13. ">Bavera 2011</a>; <a href="./references#CD009903-bbs2-0034" title="HojnackiD , ZamboniP , Lopez‐SorianoA , GalleottiR , MenegattiE , Weinstock‐GuttmanB , et al. Use of neck magnetic resonance venography, Doppler sonography and selective venography for diagnosis of chronic cerebrospinal venous insufficiency: a pilot study in multiple sclerosis patients and healthy controls. International Angiology2010;29(2):127‐39. [PUBMED: PMID: 20351669] ">Hojnacki 2010</a>; <a href="./references#CD009903-bbs2-0058" title="SimkaM , KosteckiJ , ZaniewskiM , MajewskiE , HartelM . Extracranial Doppler sonographic criteria of chronic cerebrospinal venous insufficiency in the patients with multiple sclerosis. International Angiology2010;29(2):109‐14. [PUBMED: PMID: 20351666] ">Simka 2010</a>); but this has been contested by other studies (<a href="./references#CD009903-bbs2-0018" title="BaracchiniC , PeriniP , CalabreseM , CausinF , RinaldiF , GalloP . No evidence of chronic cerebrospinal venous insufficiency at multiple sclerosis onset. Annals of Neurology2011;69(1):90‐9. [PUBMED: PMID: 21280079] ">Baracchini 2011</a>; <a href="./references#CD009903-bbs2-0022" title="CentonzeD , FlorisR , StefaniniM , RossiS , FabianoS , CastelliM , et al. Proposed chronic cerebrospinal venous insufficiency criteria do not predict multiple sclerosis risk or severity. Annals of Neurology2011;70(1):51‐8. [PUBMED: PMID: 21786298] ">Centonze 2011</a>; <a href="./references#CD009903-bbs2-0023" title="ComiG , BattagliaMA , BertolottoA , DelSetteM , GhezziA , MalferrariG , et al. Observational case‐control study of the prevalence of chronic cerebrospinal venous insufficiency inmultiple sclerosis: results from the CoSMo study. Multiple Sclerosis (Houndmills, Basingstoke, England)2013;19(11):1508‐17. [PUBMED: 24014572] ">Comi 2013</a>; <a href="./references#CD009903-bbs2-0027" title="DoeppF , PaulF , ValduezaJM , SchmiererK , SchreiberSJ . No cerebrocervical venous congestion in patients with multiple sclerosis. Annals of Neurology2010;68(2):173‐83. [PUBMED: PMID: 20695010] ">Doepp 2010</a>; <a href="./references#CD009903-bbs2-0037" title='KrogiasC , SchröderA , WiendlH , HohlfeldR , GoldR . "Chronic cerebrospinal venous insufficiency" and multiple sclerosis: critical analysis and first observation in an unselected cohort of MS patients [in German]. Der Nervenarzt2010;81(6):740‐6. [PUBMED: PMID: 20386873] '>Krogias 2010</a>; <a href="./references#CD009903-bbs2-0044" title="MarderE , GuptaP , GreenbergBM , FrohmanEM , AwadAM , BagertB , et al. No cerebral or cervical venous insufficiency in US veterans with multiple sclerosis. Archives of Neurology2011; Vol. 68, issue 12:1521‐5. [PUBMED: PMID: 21825217] ">Marder 2011</a>; <a href="./references#CD009903-bbs2-0061" title="SundströmP , WåhlinA , AmbarkiK , BirganderR , EklundA , MalmJ . Venous and cerebrospinal fluid flow in multiple sclerosis: a case‐control study. Annals of Neurology2010;68(2):255‐9. [PUBMED: PMID: 20695018] ">Sundström 2010</a>; <a href="./references#CD009903-bbs2-0064" title="TsivgoulisG , MantatzisM , BogiatziC , VadikoliasK , VoumvourakisK , PrassopoulosP , et al. Extracranial venous hemodynamics in multiple sclerosis: a case‐control study. Neurology2011;77(13):1241‐5. [PUBMED: PMID: 21849653] ">Tsivgoulis 2011</a>; <a href="./references#CD009903-bbs2-0068" title="WattjesMP , vanOostenBW , deGraafWL , SeewannA , BotJC , van denBergR , et al. No association of abnormal cranial venous drainage with multiple sclerosis: a magnetic resonance venography and flow‐quantification study. Journal of Neurology, Neurosurgery, and Psychiatry2011;82(4):429‐35. [PUBMED: PMID: 20980483] ">Wattjes 2011</a>; <a href="./references#CD009903-bbs2-0072" title="YamoutB , HerlopianA , IssaZ , HabibRH , FawazA , SalameJ , et al. Extracranial venous stenosis is an unlikely cause of multiple sclerosis. Multiple Sclerosis (Houndmills, Basingstoke, England)2010;16(11):1341‐8. [PUBMED: PMID: 21041329] ">Yamout 2010</a>). Several reviews have reported that the incidence of CCSVI varies in people with MS, ranging from 0% to 100% and from 0% to 23% in healthy controls (<a href="./references#CD009903-bbs2-0032" title="GhezziA , ComiG , FedericoA . Chronic cerebro‐spinal venous insufficiency (CCSVI) and multiple sclerosis. Neurological Sciences2011;32(1):17‐21. [PUBMED: PMID: 21161309] ">Ghezzi 2011</a>; <a href="./references#CD009903-bbs2-0079" title="ZivadinovR , RamanathanM , DolicK , MarrK , KarmonY , SiddiquiAH , et al. Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives. Expert Review of Neurotherapeutics2011;11(9):1277‐94. [PUBMED: 21864074] ">Zivadinov 2011b</a>). One study of 499 people with MS found an increased prevalence of CCSVI but with a modest sensitivity and specificity, and suggestive of a less likely primary causative role for CCSVI in the development of MS (<a href="./references#CD009903-bbs2-0078" title="ZivadinovR , MarrK , CutterG , RamanathanM , BenedictRH , KennedyC , et al. Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS. Neurology2011;77(2):138‐44. [PUBMED: PMID: 21490322] ">Zivadinov 2011a</a>). A further study found no relationship between CCSVI and HLA DRB1*1501, a genetic variation that has been consistently linked to MS (<a href="./references#CD009903-bbs2-0070" title="Weinstock‐GuttmanB , ZivadinovR , CutterG , Tamaño‐BlancoM , MarrK , BadgettD , et al. Chronic cerebrospinal vascular insufficiency is not associated with HLA DRB1*1501 status in multiple sclerosis patients. PLoS One2011;6(2):e16802. [PUBMED: PMID: 21340025] ">Weinstock‐Guttman 2011</a>). Attempts have been made to correlate CCSVI with specific symptoms of MS: in particular, an association with fatigue (which often severely affects people with MS) (<a href="./references#CD009903-bbs2-0043" title="MalagoniAM , GaleottiR , MenegattiE , ManfrediniF , BasagliaN , SalviF , et al. Is chronic fatigue the symptom of venous insufficiency associated with multiple sclerosis? A longitudinal pilot study. International Angiology2010;29(2):176‐82. [PUBMED: PMID: 20351673] ">Malagoni 2010</a>). </p> <p>The hypothesised association between CCSVI and MS implicates CCSVI as a treatable cause of MS and hence it has formed the basis for the so‐called 'liberation procedure' which is based on the technique of venous balloon angioplasty (<a href="./references#CD009903-bbs2-0074" title="ZamboniP , GaleottiR , MenegattiE , MalagoniAM , GianesiniS , BartolomeiI , et al. A prospective open‐label study of endovascular treatment of chronic cerebrospinal venous insufficiency. Journal of Vascular Surgery2009;50(6):1348‐58. [PUBMED: PMID: 19958985] ">Zamboni 2009a</a>; <a href="./references#CD009903-bbs2-0077" title="ZamboniP , GaleottiR , Weinstock‐GuttmanB , KennedyC , SalviF , ZivadinovR . Venous angioplasty in patients with multiple sclerosis: results of a pilot study. European Journal of Vascular and Endovascular Surgery2012; Vol. 43, issue 1:116‐22. [PUBMED: PMID: 21839654] ">Zamboni 2012</a>). Venous stent placement has also been used to treat CCSVI in people with MS but this treatment has been associated with a small number of serious adverse events (<a href="./references#CD009903-bbs2-0016" title="Anon . Experimental multiple sclerosis vascular shunting procedure halted at Stanford. Annals of Neurology2010;67(1):A13‐5. [PUBMED: PMID: 20186848] ">Anon 2010</a>; <a href="./references#CD009903-bbs2-0021" title="BurtonJM , AlikhaniK , GoyalM , CostelloF , WhiteC , PatryD , et al. Complications in MS patients after CCSVI procedures abroad (Calgary, AB). Canadian Journal of Neurological Sciences [Journal Canadien des Sciences Neurologiques]2011;38(5):741‐6. [PUBMED: PMID: 21856578] ">Burton 2011</a>). Much of the research on this topic has generated major interest and continuing debate in the scientific community on the definition of CCSVI as a pathological entity; the correlation between CCSVI and MS; the proposed etiopathogenetic mechanisms; and, as a consequence, on the utility of its treatment (<a href="./references#CD009903-bbs2-0017" title="BagertBA , MarderE , StüveO . Chronic cerebrospinal venous insufficiency and multiple sclerosis. Archives of Neurology2011;68(11):1379‐84. [PUBMED: PMID: 21747006] ">Bagert 2011</a>; <a href="./references#CD009903-bbs2-0024" title="D'haeseleerM , CambronM , VanopdenboschL , DeKeyserJ . Vascular aspects of multiple sclerosis. Lancet Neurology2011;10(7):657–66. [PUBMED: PMID: 21683931] ">D'haeseleer 2011</a>; <a href="./references#CD009903-bbs2-0028" title="DorneH , ZaidatOO , FiorellaD , HirshJ , PrestigiacomoC , AlbuquerqueF , et al. Chronic cerebrospinal venous insufficiency and the doubtful promise of an endovascular treatment for multiple sclerosis. AACN Clinical Issues in Critical Care Nursing2010;2(4):309‐11. ">Dorne 2010</a>; <a href="./references#CD009903-bbs2-0032" title="GhezziA , ComiG , FedericoA . Chronic cerebro‐spinal venous insufficiency (CCSVI) and multiple sclerosis. Neurological Sciences2011;32(1):17‐21. [PUBMED: PMID: 21161309] ">Ghezzi 2011</a>; <a href="./references#CD009903-bbs2-0035" title="KhanO , FilippiM , FreedmanMS , BarkhofF , Dore‐DuffyP , LassmannH , et al. Chronic cerebrospinal venous insufficiency and multiple sclerosis. Annals of Neurology2010;67(3):286‐90. [PUBMED: PMID: 20373339] ">Khan 2010</a>; <a href="./references#CD009903-bbs2-0040" title="LazzaroMA , ZaidatOO , Mueller‐KronastN , TaqiMA , WooD . Endovascular therapy for chronic cerebrospinal venous insufficiency in multiple sclerosis. Frontiers in Neurology2011;2:44. [PUBMED: PMID: 21808631] ">Lazzaro 2011</a>; <a href="./references#CD009903-bbs2-0052" title="ReekersJA , LeeMJ , BelliAM , BarkhofF . Cardiovascular and Interventional Radiological Society of Europe commentary on the treatment of chronic cerebrospinal venous insufficiency. Cardiovascular and Interventional Radiology2011;34(1):1‐2. [PUBMED: PMID: 21136256] ">Reekers 2011</a>; <a href="./references#CD009903-bbs2-0065" title="vanRensburgSJ , vanToornR . The controversy of CCSVI and iron in multiple sclerosis: is ferritin the key?. Neurology2010;75(18):1581‐2. [PUBMED: PMID: 20881276] ">van Rensburg 2010</a>; <a href="./references#CD009903-bbs2-0067" title="WaschbischA ,  ManzelA , LinkerRA , LeeD . Vascular pathology in multiple sclerosis: mind boosting or myth busting?. Experimental &amp; Translational Stroke Medicine2011;3(1):7. [PUBMED: PMID: 21756314] ">Waschbisch 2011</a>; <a href="./references#CD009903-bbs2-0079" title="ZivadinovR , RamanathanM , DolicK , MarrK , KarmonY , SiddiquiAH , et al. Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives. Expert Review of Neurotherapeutics2011;11(9):1277‐94. [PUBMED: 21864074] ">Zivadinov 2011b</a>). </p> <p>The narrative of scientific research underwent a revolutionary change as the participation of the MS community and social media became the mobilizing factors for conduct of research in this field to help the scientific community to provide evidence for or against this 'liberation procedure' (<a href="./references#CD009903-bbs2-0020" title="BenjaminyS , SchepmyerA , IllesJ , TraboulseeA . Resilience, trust, and civic engagement in the post‐CCSVI era. BMC Health Services Research2018;18(1):366. [PUBMED: 29769084] ">Benjaminy 2018</a>; <a href="./references#CD009903-bbs2-0029" title="DriedgerSM , MaierR , MarrieRA , BrouwersM . Caught in a no‐win situation: discussions about CCSVI between persons with multiple sclerosis and their neurologists ‐ a qualitative study. BMC Neurology2017;17(1):176. [PUBMED: 28882115] ">Driedger 2017</a>). </p> </section> <section id="CD009903-sec-0039"> <h3 class="title" id="CD009903-sec-0039">Description of the intervention</h3> <p>Percutaneous transluminal angioplasty (PTA) involves the insertion of a small catheter with a balloon attachment via percutaneous access to the left femoral vein. Initially a venogram is performed so that images can be obtained to identify the narrowed sections of the veins. The catheter is then inserted and advanced into the azygos and internal jugular veins. The balloon is inflated at the narrowed section of the vein, thereby increasing its diameter and improving the flow of blood. The procedure is performed with venographic control. These procedures are performed generally as day surgery — overnight hospital stay is not required. Patients receive prophylactic low‐molecular‐weight heparin during subsequent weeks, to lower the thrombotic risk. </p> </section> <section id="CD009903-sec-0040"> <h3 class="title" id="CD009903-sec-0040">How the intervention might work</h3> <p>Were the CCSVI hypothesis tenable, repairing venous stenosis and re‐establishing correct venous flow from the brain toward the heart could have therapeutic effects. </p> </section> <section id="CD009903-sec-0041"> <h3 class="title" id="CD009903-sec-0041">Why it is important to do this review</h3> <p>The original review published in 2012 did not find studies meeting inclusion criteria (<a href="./references#CD009903-bbs2-0081" title="vanZuurenEJ , FedorowiczZ , PucciE , JagannathVA , RobakEW . Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD009903.pub2] ">van Zuuren 2012</a>). There have been several studies done over the last six years which have looked at the benefit and safety of PTA intervention in people with MS. CCSVI is characterized by restricted venous outflow from the brain and spinal cord. Whether this condition is associated with MS and whether venous PTA is beneficial in persons with MS and CCSVI is controversial. We felt it was important to update the 2012 review to provide up‐to‐date evidence on the effects of PTA in in people with MS. </p> <p>The MS‐CCSVI hypothesis has generated both enthusiasm and skepticism among people with MS and the specialists who treat them (<a href="./references#CD009903-bbs2-0047" title="PaulF , WattjesMP . Chronic cerebrospinal venous insufficiency in multiple sclerosis: the final curtain. Lancet2014;383(9912):106‐8. [PUBMED: 24119383] ">Paul 2014</a>). The 'liberation procedure' has attracted considerable attention among people with MS as well as the media and on the Internet (<a href="./references#CD009903-bbs2-0029" title="DriedgerSM , MaierR , MarrieRA , BrouwersM . Caught in a no‐win situation: discussions about CCSVI between persons with multiple sclerosis and their neurologists ‐ a qualitative study. BMC Neurology2017;17(1):176. [PUBMED: 28882115] ">Driedger 2017</a>; <a href="./references#CD009903-bbs2-0048" title='PigaMA . About patients, "inventors", journalists, scientists and IRBS (to say nothing of the institutions): CCSVI and MS. Medicine and Law2014;33(4):177‐87. [PUBMED: 27351054] '>Piga 2014</a>). Consumers have been frequently exposed to media hyperbole with exaggerated claims that have led to unrealistic expectations. As a consequence, CCSVI treatment has been offered to MS participants in many countries, mostly not at conventional MS centres, in spite of the lack of confirmation of early results from Zamboni's pivotal trials (<a href="./references#CD009903-bbs2-0074" title="ZamboniP , GaleottiR , MenegattiE , MalagoniAM , GianesiniS , BartolomeiI , et al. A prospective open‐label study of endovascular treatment of chronic cerebrospinal venous insufficiency. Journal of Vascular Surgery2009;50(6):1348‐58. [PUBMED: PMID: 19958985] ">Zamboni 2009a</a>; <a href="./references#CD009903-bbs2-0077" title="ZamboniP , GaleottiR , Weinstock‐GuttmanB , KennedyC , SalviF , ZivadinovR . Venous angioplasty in patients with multiple sclerosis: results of a pilot study. European Journal of Vascular and Endovascular Surgery2012; Vol. 43, issue 1:116‐22. [PUBMED: PMID: 21839654] ">Zamboni 2012</a>). This review update attempts to highlight possible methodological issues in available clinical trials in order to provide an evidence‐based review of the effect of treating CCSVI in people with MS. Our aim in this update is to contribute so that the expectations of people with MS stay within the boundaries of the evidence‐based medicine paradigm. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009903-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009903-sec-0042"></div> <p>To assess the benefit and safety of venous PTA in people with MS and CCSVI.</p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009903-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009903-sec-0043"></div> <section id="CD009903-sec-0044"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009903-sec-0045"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials (RCTs). We did not exclude trials on the basis of duration of follow‐up. </p> </section> <section id="CD009903-sec-0046"> <h4 class="title">Types of participants</h4> <p>Participants of both genders, 17 years of age or older, with a diagnosis of MS according to the original or the revised McDonald criteria (<a href="./references#CD009903-bbs2-0046" title="McDonaldWI , CompstonA , EdanG , GoodkinD , HartungHP , LublinFD , et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology2001;50(1):121‐7. [PUBMED: PMID: 11456302] ">McDonald 2001;</a><a href="./references#CD009903-bbs2-0049" title='PolmanCH , ReingoldSC , EdanG , FilippiM , HartungHP , KapposL , et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Annals of Neurology2005;58(6):840‐6. [PUBMED: PMID: 16283615] '>Polman 2005;</a><a href="./references#CD009903-bbs2-0050" title="PolmanCH , ReingoldSC , BanwellB , ClanetM , CohenJA , FilippiM , et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Annals of Neurology2011;69(2):292‐302. [PUBMED: PMID: 21387374] ">Polman 2011</a>; <a href="./references#CD009903-bbs2-0062" title="ThompsonAJ , BanwellBL , BarkhofF , CarrollWM , CoetzeeT , ComiG , atal . Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurology2018;17(2):162‐73. ">Thompson 2018</a>), and a diagnosis of CCSVI according to Zamboni's criteria (<a href="./references#CD009903-bbs2-0074" title="ZamboniP , GaleottiR , MenegattiE , MalagoniAM , GianesiniS , BartolomeiI , et al. A prospective open‐label study of endovascular treatment of chronic cerebrospinal venous insufficiency. Journal of Vascular Surgery2009;50(6):1348‐58. [PUBMED: PMID: 19958985] ">Zamboni 2009a</a>) or other internationally recognised and validated criteria (<a href="./references#CD009903-bbs2-0080" title="ZivadinovR , BastianelloS , DakeMD , FerralH , HaackeEM , HaskalZJ , et al. International Society for Neurovascular Disease. Recommendations for multimodal non invasive and invasive screening for detection of extracranial venous abnormalities indicative of chronic cerebrospinal venous insufficiency: a position statement of the International Society for Neurovascular Disease. Journal of Vascular and Interventional Radiology : JVIR2014;25(11):1785‐1794.e17. [PUBMED: 25255703] ">Zivadinov 2014</a>; <a href="./references#CD009903-bbs2-0063" title="TraboulseeAL , KnoxKB , MachanL , ZhaoY , YeeI , RauscherA , et al. Prevalence of extracranial venous narrowing on catheter venography in people with multiple sclerosis, their siblings, and unrelated healthy controls: a blinded, case‐control study. Lancet (London, England)2014;383(9912):138‐45. [PUBMED: 24119384] ">Traboulsee 2014</a>). </p> </section> <section id="CD009903-sec-0047"> <h4 class="title">Types of interventions</h4> <p>PTA alone or in combination with MS pharmacological treatments, versus sham intervention alone or in combination with MS pharmacological treatments. We did not consider PTA associated with stenting in this review. </p> </section> <section id="CD009903-sec-0048"> <h4 class="title">Types of outcome measures</h4> <section id="CD009903-sec-0049"> <h5 class="title">Primary outcomes</h5> <section id="CD009903-sec-0050"> <h6 class="title">Safety</h6> <p> <ul id="CD009903-list-0001"> <li> <p>The total number of operative or post‐operative serious adverse events (SAEs) or adverse events (AEs). </p> </li> </ul> <ul id="CD009903-list-0002"> <li> <p>The total number of SAEs or AEs reported during the follow‐up.</p> </li> </ul> </p> <p>If not enough studies reported the total number of SAEs or AEs and person‐years, we used the number of participants with at least one SAE or AE as defined in the study. </p> </section> <section id="CD009903-sec-0051"> <h6 class="title">Benefit</h6> <p> <ul id="CD009903-list-0003"> <li> <p>Clinical measured outcomes, including disability worsening measured by Expanded Disability Status Scale (EDSS) (<a href="./references#CD009903-bbs2-0039" title="KurtzkeJF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology1983;33(11):1444‐52. [PUBMED: PMID: 6685237] ">Kurtzke 1983</a>); or any other functional outcome as reported by the authors of included studies. </p> </li> </ul> <ul id="CD009903-list-0004"> <li> <p>Patient‐reported outcomes (PROs), including quality of life (QoL) assessed by any validated disease‐specific instrument (e.g. MSQOL‐54 (<a href="./references#CD009903-bbs2-0066" title="VickreyBG , HaysRD , HarooniR , MyersLW , EllisonGW . A health‐related quality of life measure for multiple sclerosis. Quality of Life Research1995;4(3):187‐206. [PUBMED: PMID: 7613530] ">Vickrey 1995</a>), MSQLI (<a href="./references#CD009903-bbs2-0031" title="FischerJS , LaRoccaNG , MillerDM , RitvoPG , AndrewsH , PatyD . Recent developments in the assessment of quality of life in multiple sclerosis (MS). Multiple Sclerosis1999;5(4):251‐9. [PUBMED: PMID:10467384] ">Fischer 1999</a>), MusiQoL (<a href="./references#CD009903-bbs2-0057" title="SimeoniM , AuquierP , FernandezO , FlacheneckerP , StecchiS , ConstantinescuC . Validation of the Multiple Sclerosis International Quality of Life questionnaire. Multiple Sclerosis (Houndmills, Basingstoke, England)2008;14(2):219‐30. [PUBMED: PMID:17942521] ">Simeoni 2008</a>), or generic instrument, e.g. Short Form 36 (SF‐36) (<a href="./references#CD009903-bbs2-0054" title="RudickRA , MillerD , HassS , HutchinsonM , CalabresiPA , ConfavreuxC , et al. Health‐related quality of life in multiple sclerosis: effects of natalizumab. Annals of Neurology2007;62(4):335‐46. [PUBMED: PMID: 17696126] ">Rudick 2007</a>)); well‐being as measured with any visual analogue scale (VAS); fatigue measured by Modified Fatigue Impact Scale (MFIS) (<a href="./references#CD009903-bbs2-0036" title="KosD , KerckhofsE , CarreaI , VerzaR , RamosM , JansaJ . Evaluation of the Modified Fatigue Impact Scale in four different European countries. Multiple Sclerosis (Houndmills, Basingstoke, England)2005;11(1):76‐80. ">Kos 2005</a>), or other recognised and validated MS‐fatigue scale; and any other PRO as reported by the authors of included studies. </p> </li> </ul> </p> </section> </section> <section id="CD009903-sec-0052"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD009903-list-0005"> <li> <p>The number of participants experiencing at least one relapse during follow‐up. We accepted definitions of relapse as reported in the original studies. </p> </li> <li> <p>Mean change in cognitive functions' assessment through validated battery in MS (e.g. Brief Repeatable Battery of Neuropsychological Tests (BRBNT) (<a href="./references#CD009903-bbs2-0051" title="RaoSM , LeoGJ , EllingtonL , NauertzT , BernardinL , UnverzagtF . Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology1991;41(5):692‐6. [PUBMED: PMID: 1823781] ">Rao 1991</a>). </p> </li> <li> <p>Restored blood flow primary patency. Primary patency is the interval following the initial angioplasty procedure until a re‐intervention is performed to preserve patency. Secondary patency is defined as the interval following the initial angioplasty procedure until treatment of the vein is abandoned due to an inability to treat the original lesion (<a href="./references#CD009903-bbs2-0026" title="DiehmN , BaumgartnerI , JaffM , DoDD , MinarE , SchmidliJ , et al. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. European Heart Journal2007;28(7):798‐805. [PUBMED: PMID: 17317699] ">Diehm 2007</a>). </p> </li> </ul> </p> </section> </section> </section> <section id="CD009903-sec-0053"> <h3 class="title">Search methods for identification of studies</h3> <p>This review is an update of a previously published review (<a href="./references#CD009903-bbs2-0081" title="vanZuurenEJ , FedorowiczZ , PucciE , JagannathVA , RobakEW . Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD009903.pub2] ">van Zuuren 2012</a>). We conducted a systematic search with no restrictions to identify all relevant published and unpublished RCTs. We searched trials published in any language. </p> <section id="CD009903-sec-0054"> <h4 class="title">Electronic searches</h4> <p>We searched the following databases.</p> <p> <ul id="CD009903-list-0006"> <li> <p>The Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group's Specialised Register up to 30 August 2018 (<a href="./appendices#CD009903-sec-0108">Appendix 1</a>) </p> </li> <li> <p>The Cochrane Central Register of Controlled Trials (CENTRAL) (in the Cochrane Library 2018, Issue 8) (<a href="./appendices#CD009903-sec-0109">Appendix 2</a>) </p> </li> <li> <p>MEDLINE (PubMed) up to 30 August 2018 (<a href="./appendices#CD009903-sec-0110">Appendix 3</a>) </p> </li> <li> <p>Embase (embase.com) up to 30 August 2018 (<a href="./appendices#CD009903-sec-0111">Appendix 4</a>) </p> </li> </ul> </p> </section> <section id="CD009903-sec-0055"> <h4 class="title">Searching other resources</h4> <section id="CD009903-sec-0056"> <h5 class="title">References from published studies</h5> <p>We examined the bibliographies of the included and excluded studies for further references to potentially eligible RCTs. </p> </section> <section id="CD009903-sec-0057"> <h5 class="title">Ongoing trials registers</h5> <p>We searched the following ongoing trial registers.</p> <p> <ol id="CD009903-list-0007"> <li> <p>metaRegister of Controlled Trials <a href="http://www.controlled-trials.com" target="_blank">www.controlled‐trials.com</a> </p> </li> <li> <p>US National Institutes of Health Ongoing Trials Register <a href="http://www.clinicaltrials.gov" target="_blank">www.ClinicalTrials.gov</a> </p> </li> <li> <p>Australian New Zealand Clinical Trials Registry <a href="http://www.anzctr.org.au" target="_blank">www.anzctr.org.au</a> </p> </li> <li> <p>World Health Organization (WHO) International Clinical Trials Registry platform <a href="http://www.who.int/trialsearch" target="_blank">www.who.int/trialsearch</a> </p> </li> </ol> </p> </section> </section> </section> <section id="CD009903-sec-0058"> <h3 class="title" id="CD009903-sec-0058">Data collection and analysis</h3> <section id="CD009903-sec-0059"> <h4 class="title">Selection of studies</h4> <p>We used the search strategy described above to obtain titles and abstracts of studies that were relevant to the review. Two review authors (VJ and EP) independently screened the titles and abstracts and discarded studies that were not applicable. Two review authors (VJ and EP) independently assessed the retrieved abstracts, and when necessary the full text of these studies, to determine which studies satisfied the inclusion criteria. We resolved any disagreements through discussion and consensus. </p> </section> <section id="CD009903-sec-0060"> <h4 class="title">Data extraction and management</h4> <p>Two authors (VJ and GVA) independently extracted data using a predefined data extraction form. We checked data for consistency and resolved disagreements by discussion. </p> <p>We extracted from each included study the following data.</p> <p> <ul id="CD009903-list-0008"> <li> <p>Study: first author or acronym, setting, number of centres, year of publication, years that the study was conducted (recruitment and follow‐up), publication (full‐text publication, abstract publication, unpublished data). </p> </li> <li> <p>Study design: inclusion criteria, number of randomised participants, duration of follow‐up, sequence generation, allocation, blinding of participants and outcomes assessors, selective outcome reporting, early termination of trial. </p> </li> <li> <p>Participants: age, gender, inclusion and exclusion criteria, number of participants excluded after randomisation and number of losses at follow‐up. </p> </li> <li> <p>Intervention and comparison: type and intervention details.</p> </li> <li> <p>Outcomes — primary and secondary outcomes.</p> </li> <li> <p>Notes: other comments.</p> </li> </ul> </p> </section> <section id="CD009903-sec-0061"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The review authors (VJ and GVA) independently assessed the risk of bias using the Cochrane tool for assessing risk of bias as described in Chapter 8, Section 8.5 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD009903-bbs2-0033" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). We rated the following domains separately for any included study as 'low risk of bias', 'high risk of bias' and 'unclear' if the risk of bias was uncertain or unknown. </p> <p> <ul id="CD009903-list-0009"> <li> <p>Sequence generation</p> </li> <li> <p>Allocation concealment</p> </li> <li> <p>Blinding of participants, personnel</p> </li> <li> <p>Blinding of outcomes assessment</p> </li> <li> <p>Incomplete outcome data</p> </li> <li> <p>Selective outcome reporting</p> </li> <li> <p>Other bias</p> </li> </ul> </p> <p>We judged incomplete outcome data at low risk of bias when numbers and causes of dropouts were balanced (i.e. in the absence of a significant difference) between arms and appeared to be unrelated to the studied outcomes. We assessed selective outcome reporting bias by comparing outcomes reported in the study protocol along with published outcome results. </p> <p>To summarise the quality of the evidence, we used the following criteria.</p> <p> <ul id="CD009903-list-0010"> <li> <p>Low risk of bias (plausible bias unlikely to seriously alter the results) when we judged all the criteria as at low risk of bias. </p> </li> <li> <p>Unclear risk of bias (plausible bias that raises some doubt about the results) when we judged one or more criteria as at unclear risk of bias. </p> </li> <li> <p>High risk of bias (plausible bias that seriously weakens confidence in the results) when we judged one or more criteria as at high risk of bias. </p> </li> </ul> </p> </section> <section id="CD009903-sec-0062"> <h4 class="title">Measures of treatment effect</h4> <p>We planned presenting continuous outcomes where possible on the original scale as reported in each individual study, and dichotomous outcomes as risk ratios (RR) with 95% confidence intervals (95% CI) at each time point, using the Mantel‐Haenszel test, unless stated otherwise. </p> </section> <section id="CD009903-sec-0063"> <h4 class="title">Unit of analysis issues</h4> <p>Cluster and cross‐over trials or studies with multiple treatment groups have not been carried out to evaluate PTA intervention for MS. </p> </section> <section id="CD009903-sec-0064"> <h4 class="title">Dealing with missing data</h4> <p>We planned to assess the effect of missing outcome data, analysing data according to a likely scenario (i.e. assuming that treated and control group participants who contributed to missing outcome data both had an unfavourable outcome). </p> </section> <section id="CD009903-sec-0065"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to assess clinical heterogeneity within treatment comparisons by examining characteristics of study participants (i.e. differences in age, disease duration, and baseline EDSS scores, and characteristics of interventions across the trials using information reported in the <a href="./references#CD009903-sec-0126" title="">Characteristics of included studies</a> table). </p> </section> <section id="CD009903-sec-0066"> <h4 class="title">Assessment of reporting biases</h4> <p>Considering that it is not mandatory to publish results of clinical trials, it is difficult to have an estimate of the number of unpublished trials of PTA in MS. We planned to evaluate the possibility of reporting bias by means of a funnel plot, if a sufficient number of trials were identified for inclusion in this review (<a href="./references#CD009903-bbs2-0030" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. [PUBMED: PMID: 9310563] ">Egger 1997</a>). </p> </section> <section id="CD009903-sec-0067"> <h4 class="title">Data synthesis</h4> <p>We planned to perform pairwise meta‐analyses for each primary outcome using a random‐effects model for each treatment comparison with at least two studies (<a href="./references#CD009903-bbs2-0025" title="DerSimonianR , LairdN . Meta‐analysis in clinical trials. Controlled Clinical Trials1986;7:177–88. ">DerSimonian 1986</a>). Two review authors (VJ and GVA) analysed the data in Review Manager 5 (RevMan 5) (<a href="./references#CD009903-bbs2-0053" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> </section> <section id="CD009903-sec-0068"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We planned to conduct subgroup analysis if a sufficient number of studies (&gt; 10) with moderate to substantial heterogeneity were included. Although we did not identify a sufficient number of studies at this time, we planned to consider carrying out subgroup analysis based on the different subtypes of MS, disease duration and baseline EDSS level. We statistically assessed the presence of heterogeneity for all pairwise comparisons using the Chi² test and I² statistic. We considered heterogeneity as important if it was at least moderate to substantial (an I² statistic greater than 50%) (<a href="./references#CD009903-bbs2-0033" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Higgins 2011</a>). </p> </section> <section id="CD009903-sec-0069"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to conduct sensitivity analysis to assess the robustness of our review results if a sufficient number of studies were included. We planned to perform the following sensitivity analyses. </p> <p> <ul id="CD009903-list-0011"> <li> <p>Including only trials with low risk of bias.</p> </li> <li> <p>Excluding studies that did not provide complete and clear reporting of dropout data.</p> </li> </ul> </p> <section id="CD009903-sec-0070"> <h5 class="title">'Summary of findings' table</h5> <p>We present the main results of the review in a 'Summary of findings' table, as recommended by Cochrane (<a href="./references#CD009903-bbs2-0055" title="SchünemannHJ , OxmanAD , HigginsJP , VistGE , GlasziouP , GuyattGH . Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. ">Schünemann 2011</a>). The 'Summary of findings' table provides an overall grading of the quality of evidence related to each outcome based on GRADEpro GDT (<a href="http://www.gradepro.org" target="_blank">www.gradepro.org</a>; <a href="https://archie.cochrane.org/sections/documents/view?version=z1809132024500750818126076052219%26format=REVMAN#REF-GRADEproGDT-2015" target="_blank">GRADEproGDT 2015</a>). We graded the quality of evidence as high, moderate, low, or very low considering within‐study risk of bias, directness of evidence, heterogeneity, precision of effect estimates, and risk of publication bias. We based the grading of the evidence related to the study limitations on allocation concealment, blinding of participants and outcome assessor, and incomplete outcome data. </p> <p>We included an overall grading of the evidence for the following outcomes.</p> <p> <ul id="CD009903-list-0012"> <li> <p>Proportion of participants who experienced operative or postoperative serious adverse events. </p> </li> <li> <p>Proportion of participants who experienced improvement of composite functional endpoint over 12 months. </p> </li> <li> <p>Proportion of participants who experienced new relapses over 12 months.</p> </li> </ul> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009903-sec-0071" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009903-sec-0071"></div> <section id="CD009903-sec-0072"> <h3 class="title">Description of studies</h3> <section id="CD009903-sec-0073"> <h4 class="title">Results of the search</h4> <p>The initial review resulted in a total of 159 study reports from the Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System's Specialised Register to June 2012, CENTRAL (in the Cochrane Library Issue 5, 2012), MEDLINE (to June 2012) and Embase (to June 2012). From these 159 reports, no studies were included in the systematic review; there were six ongoing studies. </p> <p>For the 2019 update of this review, we identified 58 new reports. We excluded four duplicate references and 40 articles on the basis of abstracts that we considered not pertinent. We identified three new included studies (<a href="./references#CD009903-bbs2-0001" title="SiddiquiAH , ZivadinovR , BenedictRH , KarmonY , YuJ , HartneyML , et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology2014;83(5):441‐9. [PUBMED: 24975855] ">Siddiqui 2014</a>; <a href="./references#CD009903-bbs2-0002" title="TraboulseeAL , MachanL , GirardJM , RaymondJ , VosoughiR , HardyBW , et al. Safety and efficacy of venoplasty in MS: A randomized, double‐blind, sham‐controlled phase II trial. Neurology2018;91(18):e1660‐8. [PUBMED: 30266886] ">Traboulsee 2018</a>; <a href="./references#CD009903-bbs2-0003" title="ZamboniP , TesioL , GalimbertiS , MassacesiL , SalviF , D'AlessandroR , et al. Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurology2018;75(1):35‐43. [PUBMED: 29150995] ">Zamboni 2018</a>); and 11 new excluded studies. Of the three new included studies, two were publications of trials identified as ongoing trials in the 2012 review (<a href="./references#CD009903-bbs2-0001" title="SiddiquiAH , ZivadinovR , BenedictRH , KarmonY , YuJ , HartneyML , et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology2014;83(5):441‐9. [PUBMED: 24975855] ">Siddiqui 2014</a>; <a href="./references#CD009903-bbs2-0003" title="ZamboniP , TesioL , GalimbertiS , MassacesiL , SalviF , D'AlessandroR , et al. Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurology2018;75(1):35‐43. [PUBMED: 29150995] ">Zamboni 2018</a>). Of the 11 new excluded studies, four were trials identified as ongoing in the 2012 review which were terminated because of challenges with enrolment and no data reported (<a href="./references#CD009903-bbs2-0004" title="ACTRN12612000302853 . A randomised, blinded, controlled study of percutaneous transluminal angioplasty (PTA) for extracranial vein stenoses in patients with multiple sclerosis (MS). www.anzctr.org.au. ">ACTRN12612000302853</a>; <a href="./references#CD009903-bbs2-0009" title="NCT01089686 . Study to evaluate treating chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients. www.clinicaltrials.gov. ">NCT01089686</a>; <a href="./references#CD009903-bbs2-0010" title="NCT01201707 . Evaluation of angioplasty in the treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis. www.clinicaltrials.gov. ">NCT01201707</a>; <a href="./references#CD009903-bbs2-0011" title="NCT01555684 . Functional changes following percutaneous venoplasty in multiple sclerosis patients. www.clinicaltrials.gov. ">NCT01555684</a>). <a href="#CD009903-fig-0001">Figure 1</a> shows the results of the search. </p> <div class="figure" id="CD009903-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Flow diagram of studies included in the systematic review" data-id="CD009903-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_n/nCD009903-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Flow diagram of studies included in the systematic review</p> </div> </div> </div> </section> <section id="CD009903-sec-0074"> <h4 class="title">Included studies</h4> <p>We identified three new studies conducted between 2012 and 2016 in the USA, Italy and Canada (<a href="./references#CD009903-bbs2-0001" title="SiddiquiAH , ZivadinovR , BenedictRH , KarmonY , YuJ , HartneyML , et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology2014;83(5):441‐9. [PUBMED: 24975855] ">Siddiqui 2014</a>; <a href="./references#CD009903-bbs2-0002" title="TraboulseeAL , MachanL , GirardJM , RaymondJ , VosoughiR , HardyBW , et al. Safety and efficacy of venoplasty in MS: A randomized, double‐blind, sham‐controlled phase II trial. Neurology2018;91(18):e1660‐8. [PUBMED: 30266886] ">Traboulsee 2018</a>; <a href="./references#CD009903-bbs2-0003" title="ZamboniP , TesioL , GalimbertiS , MassacesiL , SalviF , D'AlessandroR , et al. Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurology2018;75(1):35‐43. [PUBMED: 29150995] ">Zamboni 2018</a>). The studies included 238 participants of ages 18 to 65 years with MS, of whom 134 were randomised to PTA and 104 to sham treatment. Follow‐up was six months (<a href="./references#CD009903-bbs2-0001" title="SiddiquiAH , ZivadinovR , BenedictRH , KarmonY , YuJ , HartneyML , et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology2014;83(5):441‐9. [PUBMED: 24975855] ">Siddiqui 2014</a>), 11 months (<a href="./references#CD009903-bbs2-0002" title="TraboulseeAL , MachanL , GirardJM , RaymondJ , VosoughiR , HardyBW , et al. Safety and efficacy of venoplasty in MS: A randomized, double‐blind, sham‐controlled phase II trial. Neurology2018;91(18):e1660‐8. [PUBMED: 30266886] ">Traboulsee 2018</a>) and 12 months (<a href="./references#CD009903-bbs2-0003" title="ZamboniP , TesioL , GalimbertiS , MassacesiL , SalviF , D'AlessandroR , et al. Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurology2018;75(1):35‐43. [PUBMED: 29150995] ">Zamboni 2018</a> ). The table '<a href="./references#CD009903-sec-0126" title="">Characteristics of included studies</a>' provides details of included studies. </p> </section> <section id="CD009903-sec-0075"> <h4 class="title">Excluded studies</h4> <p>From the 2012 review, 155 reports were excluded based on titles and abstracts; one study was excluded after full‐text review because participants were not randomised. We excluded 11 studies identified in the search for the 2019 update. Seven studies included non‐randomised patients (<a href="./references#CD009903-bbs2-0005" title="AlroughaniR , LamdhadeS , ThussuA . Endovascular treatment of chronic cerebrospinal venous insufficiency in multiple sclerosis: a retrospective study. International Journal of Neuroscience2013;123(5):324‐8. [PUBMED: 23301864] ">Alroughani 2013</a>; <a href="./references#CD009903-bbs2-0006" title="DePasqualeC , PistorioML , VerouxM , GiaquintaA , VerouxP , FornaroM . Cognitive functioning and subjective quality of life in relapsing‐remitting multiple sclerosis patients before and after percutaneous transluminal angioplasty: a preliminary report. Neuropsychiatric Disease and Treatment2014;10:1039‐44. [PUBMED: 24959079] ">De Pasquale 2014</a>; <a href="./references#CD009903-bbs2-0007" title="GhezziA , AnnovazziP , CoccoE , CoarelliG , LugaresiA , RovarisM , et al. Endovascular treatment of CCSVI in patients with multiple sclerosis: clinical outcome of 462 cases. Neurological Sciences2013;34(9):1633‐7. ">Ghezzi 2013</a>; <a href="./references#CD009903-bbs2-0008" title="HubbardD , PonecD , GoodingJ , SaxonR , SauderH , HaackeM . Clinical improvement after extracranial venoplasty in multiple sclerosis. Journal of Vascular and Interventional Radiology : JVIR2012;23(10):1302‐8. [PUBMED: 22951366] ">Hubbard 2012</a>; <a href="./references#CD009903-bbs2-0012" title="RadakD , KolarJ , SagicD , IlijevskiN , TanaskovicS , AleksicN , et al. Percutaneous angioplasty of internal jugular and azygous veins in patients with chronic cerebrospinal venous insufficiency and multiple sclerosis: early and mid‐term results. Phlebology2014;29(6):367‐75. [PUBMED: 23563645] ">Radak 2014</a>; <a href="./references#CD009903-bbs2-0013" title="ZagagliaS , BalestriniS , PerticaroliE , DanniMC , LuzziS , SilvestriniM , et al. Percutaneous transluminal angioplasty for chronic cerebrospinal venous insufficiency in multiple sclerosis: dichotomy between subjective and objective outcome scores. Neurological Sciences2013;34(12):2205‐10. [PUBMED: 23660636] ">Zagaglia 2013</a>; <a href="./references#CD009903-bbs2-0014" title="ZivadinovR , MagnanoC , GaleottiR , SchirdaC , MenegattiE , Weinstock‐GuttmanB , et al. Changes of cine cerebrospinal fluid dynamics in patients with multiple sclerosis treated with percutaneous transluminal angioplasty: a case‐control study. Journal of Vascular and Interventional Radiology : JVIR2013;24(6):829‐38. [PUBMED: 23523158] ">Zivadinov 2013</a>); and four studies, available only as protocols from ClinicalTrials.gov, were terminated due to inability to enrol adequate number of participants — no data were available (<a href="./references#CD009903-bbs2-0004" title="ACTRN12612000302853 . A randomised, blinded, controlled study of percutaneous transluminal angioplasty (PTA) for extracranial vein stenoses in patients with multiple sclerosis (MS). www.anzctr.org.au. ">ACTRN12612000302853</a>; <a href="./references#CD009903-bbs2-0009" title="NCT01089686 . Study to evaluate treating chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients. www.clinicaltrials.gov. ">NCT01089686</a>; <a href="./references#CD009903-bbs2-0010" title="NCT01201707 . Evaluation of angioplasty in the treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis. www.clinicaltrials.gov. ">NCT01201707</a>; <a href="./references#CD009903-bbs2-0011" title="NCT01555684 . Functional changes following percutaneous venoplasty in multiple sclerosis patients. www.clinicaltrials.gov. ">NCT01555684</a>). The table '<a href="./references#CD009903-sec-0127" title="">Characteristics of excluded studies</a>' provides details of excluded studies. </p> </section> </section> <section id="CD009903-sec-0076"> <h3 class="title">Risk of bias in included studies</h3> <p>We have summarised the risks of bias of the included studies in <a href="#CD009903-fig-0002">Figure 2</a> and <a href="#CD009903-fig-0003">Figure 3</a>. Considering our predefined criteria for assessing the overall risk of bias of a study (<a href="#CD009903-sec-0061">Assessment of risk of bias in included studies</a>), we judged two trials at unclear risk of bias (<a href="./references#CD009903-bbs2-0001" title="SiddiquiAH , ZivadinovR , BenedictRH , KarmonY , YuJ , HartneyML , et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology2014;83(5):441‐9. [PUBMED: 24975855] ">Siddiqui 2014</a>; <a href="./references#CD009903-bbs2-0002" title="TraboulseeAL , MachanL , GirardJM , RaymondJ , VosoughiR , HardyBW , et al. Safety and efficacy of venoplasty in MS: A randomized, double‐blind, sham‐controlled phase II trial. Neurology2018;91(18):e1660‐8. [PUBMED: 30266886] ">Traboulsee 2018</a>). </p> <div class="figure" id="CD009903-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009903-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_n/nCD009903-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD009903-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009903-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_n/nCD009903-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD009903-sec-0077"> <h4 class="title">Allocation</h4> <p>Random sequence generation was at low risk of bias in two studies (<a href="./references#CD009903-bbs2-0002" title="TraboulseeAL , MachanL , GirardJM , RaymondJ , VosoughiR , HardyBW , et al. Safety and efficacy of venoplasty in MS: A randomized, double‐blind, sham‐controlled phase II trial. Neurology2018;91(18):e1660‐8. [PUBMED: 30266886] ">Traboulsee 2018</a>; <a href="./references#CD009903-bbs2-0003" title="ZamboniP , TesioL , GalimbertiS , MassacesiL , SalviF , D'AlessandroR , et al. Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurology2018;75(1):35‐43. [PUBMED: 29150995] ">Zamboni 2018</a>); and was not reported in <a href="./references#CD009903-bbs2-0001" title="SiddiquiAH , ZivadinovR , BenedictRH , KarmonY , YuJ , HartneyML , et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology2014;83(5):441‐9. [PUBMED: 24975855] ">Siddiqui 2014</a>. Allocation concealment was at low risk of bias in all studies. </p> </section> <section id="CD009903-sec-0078"> <h4 class="title">Blinding</h4> <p>Two studies blinded either participants or personnel so we considered them to be at low risk of bias (<a href="./references#CD009903-bbs2-0001" title="SiddiquiAH , ZivadinovR , BenedictRH , KarmonY , YuJ , HartneyML , et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology2014;83(5):441‐9. [PUBMED: 24975855] ">Siddiqui 2014</a>; <a href="./references#CD009903-bbs2-0003" title="ZamboniP , TesioL , GalimbertiS , MassacesiL , SalviF , D'AlessandroR , et al. Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurology2018;75(1):35‐43. [PUBMED: 29150995] ">Zamboni 2018</a>). <a href="./references#CD009903-bbs2-0002" title="TraboulseeAL , MachanL , GirardJM , RaymondJ , VosoughiR , HardyBW , et al. Safety and efficacy of venoplasty in MS: A randomized, double‐blind, sham‐controlled phase II trial. Neurology2018;91(18):e1660‐8. [PUBMED: 30266886] ">Traboulsee 2018</a> reported blinding of participants incompletely so we judged this study as having an unclear risk of bias. As all studies used assessors who were blinded to intervention assignment, we judged all studies as having a low risk of bias for outcome assessment. </p> </section> <section id="CD009903-sec-0079"> <h4 class="title">Incomplete outcome data</h4> <p>We considered the data reporting of outcomes to be complete, with a low risk of bias in all studies. </p> </section> <section id="CD009903-sec-0080"> <h4 class="title">Selective reporting</h4> <p>We considered that all included studies have reported all outcomes based on the detailed published protocols or described in the trial methods. </p> </section> <section id="CD009903-sec-0081"> <h4 class="title">Other potential sources of bias</h4> <p>In <a href="./references#CD009903-bbs2-0003" title="ZamboniP , TesioL , GalimbertiS , MassacesiL , SalviF , D'AlessandroR , et al. Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurology2018;75(1):35‐43. [PUBMED: 29150995] ">Zamboni 2018</a>, participants in the sham group had longer disease duration. We considered that this baseline imbalance did not cause bias in the intervention effect estimate. We did not find any other potential source of bias in <a href="./references#CD009903-bbs2-0001" title="SiddiquiAH , ZivadinovR , BenedictRH , KarmonY , YuJ , HartneyML , et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology2014;83(5):441‐9. [PUBMED: 24975855] ">Siddiqui 2014</a> and <a href="./references#CD009903-bbs2-0002" title="TraboulseeAL , MachanL , GirardJM , RaymondJ , VosoughiR , HardyBW , et al. Safety and efficacy of venoplasty in MS: A randomized, double‐blind, sham‐controlled phase II trial. Neurology2018;91(18):e1660‐8. [PUBMED: 30266886] ">Traboulsee 2018</a>. </p> </section> </section> <section id="CD009903-sec-0082"> <h3 class="title" id="CD009903-sec-0082">Effects of interventions</h3> <p>See: <a href="./full#CD009903-tbl-0001"><b>Summary of findings for the main comparison</b> </a> </p> <p>See <a href="./full#CD009903-tbl-0001">summary of findings Table for the main comparison</a> for the main comparison. </p> <section id="CD009903-sec-0083"> <h4 class="title">Primary outcomes</h4> <section id="CD009903-sec-0084"> <h5 class="title">Safety</h5> <section id="CD009903-sec-0085"> <h6 class="title">Operative or post‐operative serious adverse events (SAEs)</h6> <p>The PTA intervention probably does not increase the risk of SAEs compared with the sham procedure (risk ratio (RR) versus sham 3.33, 95% confidence interval (CI) 0.36 to 30.44; I² = 0%; 3 studies, 238 participants; moderate‐quality evidence; <a href="./references#CD009903-fig-0004" title="">Analysis 1.1</a> ). <a href="./references#CD009903-bbs2-0001" title="SiddiquiAH , ZivadinovR , BenedictRH , KarmonY , YuJ , HartneyML , et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology2014;83(5):441‐9. [PUBMED: 24975855] ">Siddiqui 2014</a> reported that one patient in the PTA arm presented with an SAE at 24 hours. It was an episode of symptomatic bradycardia that was confirmed by telemetry; consequently, a cardiac consultation recommended pacemaker installation. <a href="./references#CD009903-bbs2-0002" title="TraboulseeAL , MachanL , GirardJM , RaymondJ , VosoughiR , HardyBW , et al. Safety and efficacy of venoplasty in MS: A randomized, double‐blind, sham‐controlled phase II trial. Neurology2018;91(18):e1660‐8. [PUBMED: 30266886] ">Traboulsee 2018</a> reported one asymptomatic internal jugular dissection in the PTA group that did not require intervention or hospitalization. <a href="./references#CD009903-bbs2-0003" title="ZamboniP , TesioL , GalimbertiS , MassacesiL , SalviF , D'AlessandroR , et al. Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurology2018;75(1):35‐43. [PUBMED: 29150995] ">Zamboni 2018</a> reported that no SAEs attributable to catheter venography or venous PTA or sham occurred within 24 hours from the PTA intervention. </p> </section> <section id="CD009903-sec-0086"> <h6 class="title">Operative or post‐operative adverse events</h6> <p><a href="./references#CD009903-bbs2-0001" title="SiddiquiAH , ZivadinovR , BenedictRH , KarmonY , YuJ , HartneyML , et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology2014;83(5):441‐9. [PUBMED: 24975855] ">Siddiqui 2014</a> reported that one patient in the PTA arm presented with swelling and soreness at the left side of the neck and no treatment was required. <a href="./references#CD009903-bbs2-0002" title="TraboulseeAL , MachanL , GirardJM , RaymondJ , VosoughiR , HardyBW , et al. Safety and efficacy of venoplasty in MS: A randomized, double‐blind, sham‐controlled phase II trial. Neurology2018;91(18):e1660‐8. [PUBMED: 30266886] ">Traboulsee 2018</a> reported that three (5%) of 54 sham and three (6%) of 49 PTA participants had moderate or severe pain during the intervention (P = 0.88); six (11%) sham and four (8%) PTA participants had post‐procedure pain (P = 0.62). Twenty (36%) sham participants and 17 (35%) PTA participants reported 37 and 22 AEs respectively within 48 hours post intervention. The most commonly reported periprocedural AEs were groin pain (7.7%), haematoma (8.6%), and neck pain (5.7%). <a href="./references#CD009903-bbs2-0003" title="ZamboniP , TesioL , GalimbertiS , MassacesiL , SalviF , D'AlessandroR , et al. Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurology2018;75(1):35‐43. [PUBMED: 29150995] ">Zamboni 2018</a> reported two AEs (1.7%): one vagal reaction and one episode of transient neck pain. </p> </section> <section id="CD009903-sec-0087"> <h6 class="title">Serious adverse events reported during the follow‐up</h6> <p><a href="./references#CD009903-bbs2-0001" title="SiddiquiAH , ZivadinovR , BenedictRH , KarmonY , YuJ , HartneyML , et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology2014;83(5):441‐9. [PUBMED: 24975855] ">Siddiqui 2014</a> reported that one patient in the sham arm presented with an SAE at 6 months after the venography. The event was a viral infection causing immune thrombocytopenic purpura and the authors judged it as unrelated to the intervention. <a href="./references#CD009903-bbs2-0002" title="TraboulseeAL , MachanL , GirardJM , RaymondJ , VosoughiR , HardyBW , et al. Safety and efficacy of venoplasty in MS: A randomized, double‐blind, sham‐controlled phase II trial. Neurology2018;91(18):e1660‐8. [PUBMED: 30266886] ">Traboulsee 2018</a> reported SAEs in 2% and 10% of sham and PTA participants respectively. None of the reported SAEs were judged as related to the PTA by the blinded physician. The SAEs were generalized seizure (1 sham, week 17), sepsis (2 venoplasty, weeks 20 and 25), bleeding of a previously undiagnosed cerebral aneurysm (1 venoplasty, week 46), myocardial infarction (1 venoplasty, week 28), and pulmonary embolism (1 venoplasty, week 17). <a href="./references#CD009903-bbs2-0003" title="ZamboniP , TesioL , GalimbertiS , MassacesiL , SalviF , D'AlessandroR , et al. Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurology2018;75(1):35‐43. [PUBMED: 29150995] ">Zamboni 2018</a> did not provide information about SAEs during the 12 months' follow‐up. </p> </section> <section id="CD009903-sec-0088"> <h6 class="title">Adverse events reported during the follow‐up</h6> <p><a href="./references#CD009903-bbs2-0001" title="SiddiquiAH , ZivadinovR , BenedictRH , KarmonY , YuJ , HartneyML , et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology2014;83(5):441‐9. [PUBMED: 24975855] ">Siddiqui 2014</a> reported AEs over six months: one bladder infection and one shingles event in the sham arm and one hospitalization for scheduled transobturator sling procedure in the PTA arm. <a href="./references#CD009903-bbs2-0002" title="TraboulseeAL , MachanL , GirardJM , RaymondJ , VosoughiR , HardyBW , et al. Safety and efficacy of venoplasty in MS: A randomized, double‐blind, sham‐controlled phase II trial. Neurology2018;91(18):e1660‐8. [PUBMED: 30266886] ">Traboulsee 2018</a> reported that the number of participants with any AEs reported from baseline to week 48 was 42% (23/55) for sham and 43% (21/49) for venoplasty (P = 1). The most commonly reported AEs were gastrointestinal reflux or discomfort, paraesthesia and/or lightheadedness, arthralgia, and general malaise. There were no cases of venous thrombosis up to week 48. <a href="./references#CD009903-bbs2-0003" title="ZamboniP , TesioL , GalimbertiS , MassacesiL , SalviF , D'AlessandroR , et al. Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurology2018;75(1):35‐43. [PUBMED: 29150995] ">Zamboni 2018</a> did not provide information about AEs during the 12 months' follow‐up. </p> </section> </section> <section id="CD009903-sec-0089"> <h5 class="title">Benefit</h5> <p>Clinical measured outcomes, including disability worsening measured by Expanded Disability Status Scale (EDSS) (<a href="./references#CD009903-bbs2-0039" title="KurtzkeJF . Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology1983;33(11):1444‐52. [PUBMED: PMID: 6685237] ">Kurtzke 1983</a>); or any other functional outcome as reported by the authors of included studies </p> <section id="CD009903-sec-0090"> <h6 class="title">Clinical outcomes</h6> <p><a href="./references#CD009903-bbs2-0001" title="SiddiquiAH , ZivadinovR , BenedictRH , KarmonY , YuJ , HartneyML , et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology2014;83(5):441‐9. [PUBMED: 24975855] ">Siddiqui 2014</a> reported no significant within‐ or between‐group changes in the EDSS at six months' follow‐up. <a href="./references#CD009903-bbs2-0002" title="TraboulseeAL , MachanL , GirardJM , RaymondJ , VosoughiR , HardyBW , et al. Safety and efficacy of venoplasty in MS: A randomized, double‐blind, sham‐controlled phase II trial. Neurology2018;91(18):e1660‐8. [PUBMED: 30266886] ">Traboulsee 2018</a> reported that there was little change in median EDSS score at 11 months' follow‐up in either group. <a href="./references#CD009903-bbs2-0003" title="ZamboniP , TesioL , GalimbertiS , MassacesiL , SalviF , D'AlessandroR , et al. Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurology2018;75(1):35‐43. [PUBMED: 29150995] ">Zamboni 2018</a> reported that the median (interquartile range) EDSS score was 2.0 (1.5 to 3.0) in the PTA group and 2.0 (1.5 to 2.5) in the sham group (P = 0.49) at 12 months' follow up. </p> <p>A composite functional outcome including walking control, balance, manual dexterity, postvoid residual urine volume, and visual acuity was evaluated in <a href="./references#CD009903-bbs2-0003" title="ZamboniP , TesioL , GalimbertiS , MassacesiL , SalviF , D'AlessandroR , et al. Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurology2018;75(1):35‐43. [PUBMED: 29150995] ">Zamboni 2018</a> at 12 months. A total of 30 of 73 participants (41%) in the PTA group and 18 of 37 (49%) in the sham group improved on the functional outcome — a difference of −7% (95% CI −26.7 to 10.1) in favour of the sham group (RR 0.84, 95% CI 0.55 to 1.30; 1 study, 110 participants; low‐quality evidence; <a href="./references#CD009903-fig-0005" title="">Analysis 1.2</a>). Worsening occurred in nine participants (12%) in the PTA group versus seven (19%) in the sham group; functional stability was maintained in 17 (23%) in the PTA group and 8 (22%) in the sham group. A fluctuant outcome (improvement in one or more functions and worsening in one or more) occurred in 16 participants (22%) in the PTA group and 4 (11%) in the sham group. </p> </section> <section id="CD009903-sec-0091"> <h6 class="title">Patient‐reported outcomes (PROs)</h6> <p><a href="./references#CD009903-bbs2-0001" title="SiddiquiAH , ZivadinovR , BenedictRH , KarmonY , YuJ , HartneyML , et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology2014;83(5):441‐9. [PUBMED: 24975855] ">Siddiqui 2014</a> reported that no significant between‐group changes in QoL outcomes were detected in participants. <a href="./references#CD009903-bbs2-0002" title="TraboulseeAL , MachanL , GirardJM , RaymondJ , VosoughiR , HardyBW , et al. Safety and efficacy of venoplasty in MS: A randomized, double‐blind, sham‐controlled phase II trial. Neurology2018;91(18):e1660‐8. [PUBMED: 30266886] ">Traboulsee 2018</a> reported a transient increase in MSQOL scores within 72 hours (mental scores) and 2 weeks (physical scores) in both groups. The mean improvement from baseline to week 48 for MSQOL physical score was 1.3 and 1.4 (sham vs venoplasty P = 0.95); MSQOL mental score 1.2 and −0.8 (sham vs venoplasty P = 0.55); fatigue score was 0.2 and 0.1 (sham vs venoplasty P = 0.65); pain score was 0.1 and −0.2 (sham vs venoplasty P = 0.19). There was no significant difference in the proportion of sham and venoplasty participants who had an improvement in all the other PROs from baseline to week 48. <a href="./references#CD009903-bbs2-0003" title="ZamboniP , TesioL , GalimbertiS , MassacesiL , SalviF , D'AlessandroR , et al. Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurology2018;75(1):35‐43. [PUBMED: 29150995] ">Zamboni 2018</a> did not report any PRO outcome. </p> </section> </section> </section> <section id="CD009903-sec-0092"> <h4 class="title">Secondary outcomes</h4> <section id="CD009903-sec-0093"> <h5 class="title">Proportion of participants who experienced new relapses over 12 months</h5> <p>PTA compared with sham probably makes no difference to the risk of new relapses (RR 0.87, 95% CI 0.51 to 1.49; I² = 0%; 3 studies, 235 participants; moderate‐quality evidence; <a href="./references#CD009903-fig-0006" title="">Analysis 1.3</a>). <a href="./references#CD009903-bbs2-0001" title="SiddiquiAH , ZivadinovR , BenedictRH , KarmonY , YuJ , HartneyML , et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology2014;83(5):441‐9. [PUBMED: 24975855] ">Siddiqui 2014</a> reported that there were four relapses in the treated arm (among 3 participants) and one in the sham arm. The relapses occurred at 1, 3 (2 relapses), and 6 months in the treated arm and at 5 months in sham group. <a href="./references#CD009903-bbs2-0002" title="TraboulseeAL , MachanL , GirardJM , RaymondJ , VosoughiR , HardyBW , et al. Safety and efficacy of venoplasty in MS: A randomized, double‐blind, sham‐controlled phase II trial. Neurology2018;91(18):e1660‐8. [PUBMED: 30266886] ">Traboulsee 2018</a> reported relapses in eleven participants (6 in sham, 5 in venoplasty) over 48 weeks. <a href="./references#CD009903-bbs2-0003" title="ZamboniP , TesioL , GalimbertiS , MassacesiL , SalviF , D'AlessandroR , et al. Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurology2018;75(1):35‐43. [PUBMED: 29150995] ">Zamboni 2018</a> reported that seventeen of 73 participants (23%) in the PTA group had one relapse over the 12 months compared with 12 of 39 (31%) in the sham group. </p> </section> <section id="CD009903-sec-0094"> <h5 class="title">Mean change in cognitive functions assessment</h5> <p><a href="./references#CD009903-bbs2-0001" title="SiddiquiAH , ZivadinovR , BenedictRH , KarmonY , YuJ , HartneyML , et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology2014;83(5):441‐9. [PUBMED: 24975855] ">Siddiqui 2014</a> reported that no significant between‐group changes in cognitive outcomes were detected. </p> </section> <section id="CD009903-sec-0095"> <h5 class="title">Proportion of participants who experienced post‐intervention restored venous flow</h5> <p><a href="./references#CD009903-bbs2-0001" title="SiddiquiAH , ZivadinovR , BenedictRH , KarmonY , YuJ , HartneyML , et al. Prospective randomized trial of venous angioplasty in MS (PREMiSe). Neurology2014;83(5):441‐9. [PUBMED: 24975855] ">Siddiqui 2014</a> reported that improvement of venous haemodynamic insufficiency severity score (VHISS) was observed in treatment arm (P = 0.02) and sham arm (P = 0.04) at month 1 post intervention but did not reach more than 75% restoration of venous outflow compared to baseline. No differences in VHISS improvement were detected between treated and sham groups (P = 0.89). <a href="./references#CD009903-bbs2-0003" title="ZamboniP , TesioL , GalimbertiS , MassacesiL , SalviF , D'AlessandroR , et al. Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: a randomized clinical trial. JAMA Neurology2018;75(1):35‐43. [PUBMED: 29150995] ">Zamboni 2018</a> reported that blinded flow assessment at 12 months revealed restored flow in 38 of 71 patients (54%) in the PTA group and 14 of 37 (38%) in the sham group. <a href="./references#CD009903-bbs2-0002" title="TraboulseeAL , MachanL , GirardJM , RaymondJ , VosoughiR , HardyBW , et al. Safety and efficacy of venoplasty in MS: A randomized, double‐blind, sham‐controlled phase II trial. Neurology2018;91(18):e1660‐8. [PUBMED: 30266886] ">Traboulsee 2018</a> did not report the outcome. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009903-sec-0096" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009903-sec-0096"></div> <section id="CD009903-sec-0097"> <h3 class="title" id="CD009903-sec-0097">Summary of main results</h3> <p>The aim of this updated review was to assess the effects of percutaneous transluminal angioplasty (PTA) for the treatment of CCSVI in people with MS. We added three new studies to the original review; four studies previously identified as ongoing had been terminated and provided no outcome data. The three studies we included comprised 238 people of ages 18 to 65 years with mainly relapsing‐remitting MS; 134 were randomised to PTA and 104 to sham treatment. Durations of studies ranged from six to 12 months. </p> <p>Serious adverse events (SAEs) were reported in all studies and the results showed that the PTA intervention probably did not increase the risk of operative or post‐operative SAEs compared with the sham procedure. Our confidence in the long‐term safety of the PTA intervention is low because information on SAEs during follow‐up was poorly reported. Moderate or severe pain during or post venography was reported in the PTA and sham participants in all studies. </p> <p>Patient‐centred outcomes such as disability worsening — measured by the Expanded Disability Status Scale (three studies), a functional outcome including walking control, balance, manual dexterity, postvoid residual urine volume, and visual acuity (one study), and relapses over 12 months post intervention (three studies) — were available to evaluate benefit of the PTA intervention. We detected no differences overall in these outcomes between treatment groups and there was no heterogeneity between studies. Quality of life was reported in two studies with no difference between treatment groups. While the data available were limited they were of moderate quality (GRADE), so we have moderate‐certainty evidence that PTA compared with sham makes no difference to all these outcomes. </p> <p>Venous PTA was not effective in restoring blood flow assessed at one month (one study) or 12 months (one study) post intervention. </p> </section> <section id="CD009903-sec-0098"> <h3 class="title" id="CD009903-sec-0098">Overall completeness and applicability of evidence</h3> <p>The review includes representation from people with MS of age range 18 to 65 years, of mainly the RRMS subtype and evaluated in populations in Italy, Canada and USA. Two were multicentric studies and hence overall applicable. The evidence required had to provide information about the safety of the procedure, improvement in disability, relapses and patient‐reported outcomes, as well on the effectiveness of the procedure and long‐term safety and effectiveness. There were data available on safety and primary effectiveness of the procedure regarding patency but the outcomes reflecting clinical improvement were addressed only partially in the trials of the review. </p> <p>The applicability of the available evidence needs to be considered in light of the fact that some of the non‐randomised excluded studies have been well‐documented studies of either poor association of CCSVI with MS or ineffectiveness of PTA for CCSVI; and they were undertaken during a period similar to that of the studies included in the review. It should also be noted that the most recent international practice of countries outside the aforementioned countries excludes this form of treatment. </p> </section> <section id="CD009903-sec-0099"> <h3 class="title" id="CD009903-sec-0099">Quality of the evidence</h3> <p>Our review included three studies, which involved 238 participants. We considered the quality of the evidence for safety and benefit outcomes to be moderate because of small patient numbers included in these studies; and imprecision. We further downgraded the quality of evidence for patient‐reported outcomes due to incomplete outcomes data. </p> </section> <section id="CD009903-sec-0100"> <h3 class="title" id="CD009903-sec-0100">Potential biases in the review process</h3> <p>We made every attempt to limit bias in the review process by ensuring a comprehensive search of potentially eligible studies (up to August 2018) since the publication of the original review in 2012, to reduce the possibility that we might overlook additional studies eligible for inclusion. The authors' independent assessments of eligibility of studies for inclusion in this review minimised the potential for additional bias. </p> </section> <section id="CD009903-sec-0101"> <h3 class="title" id="CD009903-sec-0101">Agreements and disagreements with other studies or reviews</h3> <p>To our knowledge, no systematic reviews are available to compare with our review.</p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009903-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/urn:x-wiley:14651858:media:CD009903:CD009903-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_t/tCD009903-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Flow diagram of studies included in the systematic review" data-id="CD009903-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_n/nCD009903-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Flow diagram of studies included in the systematic review</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/full#CD009903-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_n/nCD009903-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009903-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/urn:x-wiley:14651858:media:CD009903:CD009903-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_t/tCD009903-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD009903-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_n/nCD009903-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/full#CD009903-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_n/nCD009903-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009903-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/urn:x-wiley:14651858:media:CD009903:CD009903-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_t/tCD009903-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD009903-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_n/nCD009903-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/full#CD009903-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_n/nCD009903-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009903-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/urn:x-wiley:14651858:media:CD009903:CD009903-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_t/tCD009903-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 PTA vs SHAM, Outcome 1 Proportion of participants who experienced operative or postoperative serious adverse events." data-id="CD009903-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_n/nCD009903-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 PTA vs SHAM, Outcome 1 Proportion of participants who experienced operative or postoperative serious adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/references#CD009903-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_n/nCD009903-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009903-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/urn:x-wiley:14651858:media:CD009903:CD009903-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_t/tCD009903-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 PTA vs SHAM, Outcome 2 Proportion of participants who experienced improvement of composite functional endpoint over 12 months." data-id="CD009903-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_n/nCD009903-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 PTA vs SHAM, Outcome 2 Proportion of participants who experienced improvement of composite functional endpoint over 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/references#CD009903-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_n/nCD009903-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009903-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/urn:x-wiley:14651858:media:CD009903:CD009903-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_t/tCD009903-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 PTA vs SHAM, Outcome 3 Proportion of participants who experienced new relapses over 12 months." data-id="CD009903-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_n/nCD009903-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 PTA vs SHAM, Outcome 3 Proportion of participants who experienced new relapses over 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/references#CD009903-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/media/CDSR/CD009903/image_n/nCD009903-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009903-tbl-0001"> <div class="table-heading"><span class="table-title"></span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> patients with multiple sclerosis and chronic cerebrospinal venous insufficiency (CCSVI) </p> <p><b>Settings:</b> MS centres and their associated colour Doppler ultrasonography (ECD) and angiography units </p> <p><b>Intervention:</b> venous percutaneous transluminal angioplasty (PTA) </p> <p><b>Comparison:</b> catheter venography without venous angioplasty (sham) </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect (95% CI)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Reasons for downgrading our confidence in the<br/> evidence</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk with sham procedure</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk with intervention (95%CI)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants who experienced operative or postoperative serious adverse events </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>0 per 100</p> <p>(0 to 0)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 3.33</p> <p>(0.36 to 30.44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>238</p> <p>(3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 1 level due to <b>imprecision</b>, wide CI </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants who experienced improvement of composite functional endpoint over 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>49 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>41 per 100</p> <p>(27 to 64)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.84,</p> <p>(0.55 to 1.30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> <p>(1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 1 level due to <b>imprecision</b>, wide CI </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proportion of participants who experienced new relapses over 12 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>18 per 100</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>16 per 100</p> <p>(4 to 27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RR 0.87</p> <p>(0.51 to 1.49)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235</p> <p>(3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>moderate</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Downgraded 1 level due to <b>imprecision</b>, wide CI </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>* The basis for the <b>assumed risk</b> is the sham group risk across studies included in the meta‐analysis. The <b>corresponding risk</b> (and its 95% CI) is based on the assumed risk with sham procedure and the <b>relative effect</b> of the PTA intervention (and its 95% CI). </p> <p><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-title"></span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/full#CD009903-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009903-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>ntigen</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Substance or molecule that, when introduced into the body, triggers the production of an antibody by the immune system, which will then kill or neutralise the antigen that is recognised as a foreign and potentially harmful invader </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Autoreactive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immune response acting against own tissue</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Ataxia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neurological sign and symptom that consists of gross lack of coordination of muscle movements </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Axon</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Part of the neuron that conducts electrical impulses away from the neuron's cell body</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Central nervous system</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Part of the nervous system that integrates the information that it receives from, and coordinates the activity of, all parts of the body. It comprises the brain and the spinal cord </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Cognitive impairment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Condition associated with forgetfulness, difficulty concentrating, or making decisions that affect everyday life. Cognitive impairment ranges from mild to severe. With mild impairment, people may begin to notice changes in cognitive functions, but still be able to do their everyday activities. Severe levels of impairment can lead to losing the ability to understand the meaning or importance of something and the ability to talk or write, resulting in the inability to live independently. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Congestion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Accumulation or overfilling of the blood vessels</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Demyelination</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Loss of the myelin sheath insulating the nerves</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dysarthria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Having a problem with articulating</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Erythrocyte extravasation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Leakage of red blood cells into the surrounding tissue</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gliosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Proliferation of astrocytes (glial cells) in damaged areas of the central nervous system </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HLA‐DR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Major histocompatability complex (MHC) class II cell surface receptor encoded by the human leukocyte antigen complex on chromosome 6 region 6p21.31. HLA‐DR is also involved in several autoimmune conditions, disease susceptibility and disease resistance. It is also closely linked to HLA‐DQ and this linkage often makes it difficult to resolve the more causative factor in disease </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HLA‐DQ</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A cell surface receptor type protein (MHC class II type) found on antigen presenting cells. The DQ loci are in close genetic linkage to HLA‐DR. When tolerance to self‐proteins is lost, DQ may become involved in autoimmune disease </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Immuno‐mediated disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Conditions that result from abnormal activity of the body's immune system</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Inflammation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Response of vascular tissues to harmful stimuli and a protective attempt to remove the injurious stimuli and to initiate the healing process. A cascade of biochemical events propagates and matures the inflammatory response, involving the local vascular system, the immune system and various cells within the injured tissue </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Major histocompatability complex (MHC)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A large genomic region or gene family found in most vertebrates that encodes MHC molecules. MHC molecules play an important role in the immune system and autoimmunity </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Neuron</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An electrically excitable cell that processes and transmits information by electrical and chemical signalling. Chemical signalling occurs via synapses, specialised connections with other cells. Neurons connect to each other to form networks. Neurons are the core components of the nervous system </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathological</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Altered or caused by disease</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Pathogenesis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>The mechanism by which the disease is caused</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Phagocytosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mechanism used to remove pathogens and cell debris</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Polygenic disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Disease controlled by several genes at once</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Relapse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An objective new/re‐emerging neurological abnormality present for at least 24 hours in the absence of fever/infection </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reversible</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Capable of returning to an original condition/situation</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Stenosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Abnormal narrowing in a blood vessel</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Tremor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Involuntary, somewhat rhythmic, muscle contraction and relaxation involving to‐and‐fro movements of 1 or more body parts </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venogram</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>An X‐ray test that takes pictures of blood flow through the veins in a certain area of the body </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venotopic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Located in the veins</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venous angioplasty</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>A procedure that can be performed during a venogram to open or bypass veins. It can also be used for placement of a stent, which keeps a vessel or tissue in an open position to allow for improved blood flow </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Venous congestion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dilation of veins and capillaries due to impaired venous drainage</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vertigo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Type of dizziness, where there is a feeling of motion when one is stationary</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Glossary of terms</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/full#CD009903-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009903-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">PTA vs SHAM</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Proportion of participants who experienced operative or postoperative serious adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.33 [0.36, 30.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Proportion of participants who experienced improvement of composite functional endpoint over 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.55, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Proportion of participants who experienced new relapses over 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.51, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">PTA vs SHAM</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009903.pub3/references#CD009903-tbl-0003">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009903.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD009903-note-0008">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD009903-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD009903-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD009903-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD009903-note-0007">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD009903-note-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD009903-note-0001">繁體中文</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD009903-note-0004">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009903\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009903\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009903\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009903\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009903\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009903\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009903\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009903\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009903\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009903\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009903\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009903\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009903\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009903\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009903\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009903\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009903\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009903\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=jU9oKp1Y&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009903.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009903.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009903.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009903.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009903.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740714466782"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009903.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740714466786"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009903.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d6f637ec89377',t:'MTc0MDcxNDQ2Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 